136 results on '"Bahendeka S"'
Search Results
2. IDF2022-0450 The state of patient-centered diabetes prevention in 44 low and middle-income countries
- Author
-
Rahim, N., primary, Flood, D., additional, Bahendeka, S., additional, Guwatudde, D., additional, Marcus, M., additional, Ali, M., additional, Mayige, M., additional, Davies, J., additional, and Manne-Goehler, J., additional
- Published
- 2023
- Full Text
- View/download PDF
3. IDF2022-1239 Nurse-led management of hypertension and cardiovascular disease risk in diabetes: A cluster randomised clinical trial
- Author
-
Lumu, W., primary, Kibirige, D., additional, Mutebi, R. Kasoma, additional, Wesonga, R., additional, and Bahendeka, S., additional
- Published
- 2023
- Full Text
- View/download PDF
4. IDF2022-0582 Aspirin Use among Individuals with Diabetes in 48 Low-, Middle-, and High-income Countries
- Author
-
Yoo, K., primary, Bahendeka, S., additional, Damasceno, A., additional, Davies, J., additional, Geldsetzer, P., additional, Guwatudde, D., additional, Huffman, M.D., additional, Manne-Goehler, J., additional, Moghaddam, S.S., additional, Singh, K., additional, Sussman, J.B., additional, and Flood, D., additional
- Published
- 2023
- Full Text
- View/download PDF
5. The INTERPRET–DD study of diabetes and depression: a protocol
- Author
-
Lloyd, C. E., Sartorius, N., Cimino, L. C., Alvarez, A., de Braude, Guinzbourg M., Rabbani, G., Ahmed, Uddin H., Papelbaum, M., de Freitas, Regina S., Ji, L., Yu, X., Gaebel, W., Müssig, K., Chaturvedi, S. K., Srikanta, S. S., Burti, L., Bulgari, V., Musau, A., Ndetei, D., Heinze, G., Nava, Romo F., Taj, R., Khan, A., Kokoszka, A., Papasz-Siemieniuk, A., Starostina, E. G., Bobrov, A. E., Lecic-Tosevski, D., Lalic, N. M., Udomratn, P., Tangwongchai, S., Bahendeka, S., Basangwa, D., and Mankovsky, B.
- Published
- 2015
- Full Text
- View/download PDF
6. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries; results from the INTERPRET-DD prospective study
- Author
-
Lloyd, Cathy E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, Arie, Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U, van Dam, Kristina, Vukovic, O., and Wölwer, W.
- Subjects
mental disorders ,behavioral disciplines and activities - Abstract
Aims\ud To examine the factors that associated with changes in depression in people with type 2 diabetes living in 12 different countries.\ud Methods\ud People with type 2 diabetes treated in out-patient settings aged 18-65 years underwent a psychiatric assessment to diagnose Major Depressive Disorder (MDD) at baseline and follow-up. At both time points participants completed the Patient Health Questionnaire (PHQ-9), the WHO 5-item Well-being scale (WHO-5) and the Problem Areas in Diabetes (PAID) scale which measures diabetes-related distress. A composite stress score (CSS) (the occurrence of stressful life events and their reported degree of 'upset') between baseline and follow-up was calculated. Demographic data and medical record information were collected. Separate regression analyses were conducted with MDD and PHQ-9 scores as the dependent variables.\ud Results\ud In total there were 7.4% (120) incident cases of MDD with 81.5% (1317) continuing to remain free of a diagnosis of MDD. Univariate analyses demonstrated that those with MDD were more likely to be female, less likely to be physically active, more likely to have diabetes complications at baseline and have higher CSS. Mean scores for the WHO-5, PAID and PHQ-9 were poorer in those with incident MDD compared with those who had never had a diagnosis of MDD. Regression analyses demonstrated that higher PHQ-9, lower WHO-5 scores and greater CSS were significant predictors of incident MDD. Significant predictors of PHQ-9 were baseline PHQ-9 score, WHO-5, PAID and CSS.\ud Conclusion\ud This study demonstrates the importance of psychosocial factors in addition to physiological variables in the development of depressive symptoms and incident MDD in people with type 2 diabetes. Stressful life events, depressive symptoms and diabetes-related distress all play a significant role which has implications for practice. A more holistic approach to care, which recognises the interplay of these psychosocial factors may help to mitigate their impact on diabetes self-management as well as MDD, thus early screening and treatment for symptoms is recommended.
- Published
- 2020
7. Obesity and cardiovascular disease risk among Africans residing in Europe and Africa : the RODAM study
- Author
-
Commodore-Mensah, Y, Agyemang, C, Aboagye, J A, Echouffo-Tcheugui, J B, Beune, E, Smeeth, L, Klipstein-Grobusch, K, Danquah, I, Schulze, M, Boateng, D, Meeks, K A C, Bahendeka, S, Ahima, R S, Commodore-Mensah, Y, Agyemang, C, Aboagye, J A, Echouffo-Tcheugui, J B, Beune, E, Smeeth, L, Klipstein-Grobusch, K, Danquah, I, Schulze, M, Boateng, D, Meeks, K A C, Bahendeka, S, and Ahima, R S
- Published
- 2020
8. Obesity and cardiovascular disease risk among Africans residing in Europe and Africa: the RODAM study
- Author
-
Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Global Health team 1, Commodore-Mensah, Y, Agyemang, C, Aboagye, J A, Echouffo-Tcheugui, J B, Beune, E, Smeeth, L, Klipstein-Grobusch, K, Danquah, I, Schulze, M, Boateng, D, Meeks, K A C, Bahendeka, S, Ahima, R S, Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Global Health team 1, Commodore-Mensah, Y, Agyemang, C, Aboagye, J A, Echouffo-Tcheugui, J B, Beune, E, Smeeth, L, Klipstein-Grobusch, K, Danquah, I, Schulze, M, Boateng, D, Meeks, K A C, Bahendeka, S, and Ahima, R S
- Published
- 2020
9. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015
- Author
-
Tabesh, M, Magliano, DJ, Tanamas, SK, Surmont, F, Bahendeka, S, Chiang, C-E, Elgart, JF, Gagliardino, JJ, Kalra, S, Krishnamoorthy, S, Luk, A, Maegawa, H, Motala, AA, Pirie, F, Ramachandran, A, Tayeb, K, Vikulova, O, Wong, J, Shaw, JE, Tabesh, M, Magliano, DJ, Tanamas, SK, Surmont, F, Bahendeka, S, Chiang, C-E, Elgart, JF, Gagliardino, JJ, Kalra, S, Krishnamoorthy, S, Luk, A, Maegawa, H, Motala, AA, Pirie, F, Ramachandran, A, Tayeb, K, Vikulova, O, Wong, J, and Shaw, JE
- Abstract
AIM: Optimal treatment of cardiovascular disease is essential to decrease mortality among people with diabetes, but information is limited on how actual treatment relates to guidelines. We analysed changes in therapeutic approaches to anti-hypertensive and lipid-lowering medications in people with Type 2 diabetes from 2006 and 2015. METHODS: Summary data from clinical services in seven countries outside North America and Western Europe were collected for 39 684 people. Each site summarized individual-level data from outpatient medical records for 2006 and 2015. Data included: demographic information, blood pressure (BP), total cholesterol levels and percentage of people taking statins, anti-hypertensive medication (angiotensin-converting enzyme inhibitors, calcium channel blockers, angiotensin II receptor blockers, thiazide diuretics) and antiplatelet drugs. RESULTS: From 2006 to 2015, mean cholesterol levels decreased in six of eight sites (range: -0.5 to -0.2), whereas the proportion with BP levels > 140/90 mmHg increased in seven of eight sites. Decreases in cholesterol paralleled increases in statin use (range: 3.1 to 47.0 percentage points). Overall, utilization of anti-hypertensive medication did not change. However, there was an increase in the use of angiotensin II receptor blockers and a decrease in angiotensin-converting enzyme inhibitors. The percentage of individuals receiving calcium channel blockers and aspirin remained unchanged. CONCLUSIONS: Our findings indicate that control of cholesterol levels improved and coincided with increased use of statins. The percentage of people with BP > 140/90 mmHg was higher in 2015 than in 2006. Hypertension treatment shifted from using angiotensin-converting enzyme inhibitors to angiotensin II receptor blockers. Despite the potentially greater tolerability of angiotensin II receptor blockers, there was no associated improvement in BP levels.
- Published
- 2019
10. Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care
- Author
-
Kalra, S, Czupryniak, L, Kilov, G, Lamptey, R, Kumar, A, Unnikrishnan, AG, Boudiba, A, Abid, M, Akanov, ZA, Latheef, A, Araz, M, Audehm, R, Bahendeka, S, Balde, N, Chaudhary, S, Deerochanawong, C, Fasanmade, O, Iraqi, H, Latt, TS, Mbanya, JC, Rodriguez-Saldana, J, Hyun, KS, Latif, ZA, Lushchyk, M, Megallaa, M, Naseri, MW, Nguyen, QB, Ramaiya, K, Randeree, H, Raza, SA, Shaikh, K, Shrestha, D, Sobngwi, E, Somasundaram, N, Sukor, N, Tan, R, Kalra, S, Czupryniak, L, Kilov, G, Lamptey, R, Kumar, A, Unnikrishnan, AG, Boudiba, A, Abid, M, Akanov, ZA, Latheef, A, Araz, M, Audehm, R, Bahendeka, S, Balde, N, Chaudhary, S, Deerochanawong, C, Fasanmade, O, Iraqi, H, Latt, TS, Mbanya, JC, Rodriguez-Saldana, J, Hyun, KS, Latif, ZA, Lushchyk, M, Megallaa, M, Naseri, MW, Nguyen, QB, Ramaiya, K, Randeree, H, Raza, SA, Shaikh, K, Shrestha, D, Sobngwi, E, Somasundaram, N, Sukor, N, and Tan, R
- Abstract
Premixed insulins are an important tool for glycemic control in persons with diabetes. Equally important in diabetes care is the selection of the most appropriate insulin regimen for a particular individual at a specific time. Currently, the choice of insulin regimens for initiation or intensification of therapy is a subjective decision. In this article, we share insights, which will help in rational and objective selection of premixed formulations for initiation and intensification of insulin therapy. The glycemic status and its variations in a person help to identify the most appropriate insulin regimen and formulation for him or her. The evolution of objective glucometric indices has enabled better glycemic monitoring of individuals with diabetes. Management of diabetes has evolved from a 'glucocentric' approach to a 'patient-centered' approach; patient characteristics, needs, and preferences should be evaluated when considering premixed insulin for treatment of diabetes.Funding: Novo Nordisk, India.
- Published
- 2018
11. High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
- Author
-
Gupta, R. K., Goodall, R. L., Ranopa, M., Kityo, C., Munderi, P., Lyagoba, F., Mugarura, L., Gilks, C. F., Kaleebu, P., Pillay, D., Grosskurth, H., Kabuye, G., Nsibambi, D., Kasirye, R., Zalwango, E., Nakazibwe, M., Kikaire, B., Nassuna, G., Massa, R., Fadhiru, K., Namyalo, M., Zalwango, A., Generous, L., Khauka, P., Rutikarayo, N., Nakahima, W., Mugisha, A., Todd, J., Levin, J., Muyingo, S., Ruberantwari, A., Yirrell, D., Ndembi, N., Hughes, P., Aber, M., Medina Lara, A., Foster, S., Amurwon, J., Mugyenyi, P., Ssali, F., Tumukunde, D., Otim, T., Kabanda, J., Musana, H., Akao, J., Kyomugisha, H., Byamukama, A., Sabiiti, J., Komugyena, J., Wavamunno, P., Mukiibi, S., Drasiku, A., Byaruhanga, R., Labeja, O., Katundu, P., Tugume, S., Awio, P., Namazzi, A., Bakeinyaga, T. G., Katabira, H., Abaine, D., Tukamushaba, J., Anywar, W., Ojiambo, W., Angweng, E., Murungi, S., Haguma, W., Atwiine, S., Kigozi, J., Latif, A., Hakim, J., Robertson, V., Reid, A., Chidziva, E., Bulaya-Tembo, R., Musoro, G., Taziwa, F., Chimbetete, C., Chakonza, L., Mawora, A., Muvirimi, C., Tinago, G., Svovanapasis, P., Simango, M., Chirema, O., Machingura, J., Mutsai, S., Phiri, M., Bafana, T., Chirara, M., Muchabaiwa, L., Muzambi, M., Katabira, E., Ronald, A., Kambungu, A., Lutwama, F., Nanfuka, A., Walusimbi, J., Nabankema, E., Nalumenya, R., Namuli, T., Kulume, R., Namata, I., Nyachwo, L., Florence, A., Kusiima, A., Lubwama, E., Nairuba, R., Oketta, F., Buluma, E., Waita, R., Ojiambo, H., Sadik, F., Wanyama, J., Nabongo, P., Ochai, R., Muhweezi, D., Gilks, C., Boocock, K., Puddephatt, C., Winogron, D., Bohannon, J., Darbyshire, J., Gibb, M. D., Burke, A., Bray, D., Babiker, A., Walker, S. A., Wilkes, H., Rauchenberger, M., Sheehan, S., Peto, L., Taylor, K., Spyer, M., Ferrier, A., Naidoo, B., Dunn, D., Goodall, R., Nanfuka, R., Mufuka-Kapuya, C., Kapaata, A., Katuramur, M., Magala, R., Magambo, B., Mataruka, K., McCormick, A., Musunga, T., Nabankkema, M., Nkalubo, J., Nkurunziza, P., Parry, C., Nyanzi Wakholi, B., Weller, I., Bahendeka, S., Bassett, M., Chogo Wapakhabulo, A., Gazzard, B., Mapuchere, C., Mugurungi, O., Burke, C., Jones, S., Newland, C., Rahim, S., Rooney, J., Smith, M., Snowden, W., Steens, J.- M., Breckenridge, A., McLaren, A., Hill, C., Matenga, J., Pozniak, A., Serwadda, D., Peto, T., Palfreeman, A., and Borok, M.
- Subjects
Anti-HIV Agents ,HIV ,Viral Load ,viral resuppression ,Dideoxynucleosides ,failure ,resistance ,Drug Combinations ,Lamivudine ,Africa ,HIV/AIDS ,Humans ,Nevirapine ,Viremia ,Zidovudine - Abstract
In a randomized comparison of nevirapine or abacavir with zidovudine plus lamivudine, routine viral load monitoring was not performed, yet 27% of individuals with viral failure at week 48 experienced resuppression by week 96 without switching. This supports World Health Organization recommendations that suspected viral failure should trigger adherence counseling and repeat measurement before a treatment switch is considered.
- Published
- 2013
12. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015
- Author
-
Tabesh, M., primary, Magliano, D. J., additional, Tanamas, S. K., additional, Surmont, F., additional, Bahendeka, S., additional, Chiang, C.‐E., additional, Elgart, J. F., additional, Gagliardino, J. J., additional, Kalra, S., additional, Krishnamoorthy, S., additional, Luk, A., additional, Maegawa, H., additional, Motala, A. A., additional, Pirie, F., additional, Ramachandran, A., additional, Tayeb, K., additional, Vikulova, O., additional, Wong, J., additional, and Shaw, J. E., additional
- Published
- 2018
- Full Text
- View/download PDF
13. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries
- Author
-
Lloyd, C. E., primary, Nouwen, A., additional, Sartorius, N., additional, Ahmed, H. U., additional, Alvarez, A., additional, Bahendeka, S., additional, Basangwa, D., additional, Bobrov, A. E., additional, Boden, S., additional, Bulgari, V., additional, Burti, L., additional, Chaturvedi, S. K., additional, Cimino, L. C., additional, Gaebel, W., additional, de Girolamo, G., additional, Gondek, T. M., additional, de Braude, M. Guinzbourg, additional, Guntupalli, A., additional, Heinze, M. G., additional, Ji, L., additional, Hong, X., additional, Khan, A., additional, Kiejna, A., additional, Kokoszka, A., additional, Kamala, T., additional, Lalic, N. M., additional, Lecic Tosevski, D., additional, Mankovsky, B., additional, Li, M., additional, Musau, A., additional, Müssig, K., additional, Ndetei, D., additional, Rabbani, G., additional, Srikanta, S. S., additional, Starostina, E. G., additional, Shevchuk, M., additional, Taj, R., additional, Vukovic, O., additional, Wölwer, W., additional, and Xin, Y., additional
- Published
- 2018
- Full Text
- View/download PDF
14. Innovative ways of studying the effect of migration on obesity and diabetes beyond the common designs: lessons from the RODAM study
- Author
-
Agyemang C, Beune E, Meeks K, Addo J, Ad, Aikins, Bahendeka S, Ina Danquah, Fp, Mockenhaupt, Mb, Schulze, Klipstein-Grobusch K, Smeeth L, and Stronks K
- Subjects
Europe ,sub-Saharan Africa ,obesity ,ethnic minority ,Journal Article ,population characteristics ,type 2 diabetes ,migrants ,Review ,social sciences ,geographic locations - Abstract
Type 2 diabetes and obesity are major global public health problems, with migrant populations in high-income countries being particularly affected. Type 2 diabetes and obesity are also major threats in low- and middle-income countries, from which most migrant populations originate. Transitioning of societies and the resulting changes in lifestyles are thought to be major driving forces, but the key specific factors within this broad category still need to be determined. Migrant studies provide a unique opportunity to understand the potential underlying causes of these conditions, but current research is mainly geared toward analyzing the differences between migrants and the host populations in the countries of settlement. For better understanding, there is a need to extend migrant health research across national boundaries. This review discusses innovative ways of studying the effect of migration on type 2 diabetes and obesity beyond the common designs and the relevance of extending migrant health studies across national boundaries in the current era of increasing global migration. Specifically, we describe the burden and different methods for conducting migrant studies. We use the Research on Obesity and Diabetes among African Migrants (RODAM) study as a case study, discussing the methods, some results, and lessons learned, including challenges and an essential recipe for success that may guide future migrant health research.
- Published
- 2016
15. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015.
- Author
-
Tabesh, M., Magliano, D. J., Tanamas, S. K., Surmont, F., Bahendeka, S., Chiang, C.‐E., Elgart, J. F., Gagliardino, J. J., Kalra, S., Krishnamoorthy, S., Luk, A., Maegawa, H., Motala, A. A., Pirie, F., Ramachandran, A., Tayeb, K., Vikulova, O., Wong, J., and Shaw, J. E.
- Subjects
CARDIOVASCULAR disease treatment ,PEOPLE with diabetes ,CHOLESTEROL ,BLOOD pressure ,ACE inhibitors ,STATINS (Cardiovascular agents) ,ANGIOTENSIN-receptor blockers ,TYPE 2 diabetes complications ,CARDIOVASCULAR diseases risk factors ,THERAPEUTICS - Abstract
Aim: Optimal treatment of cardiovascular disease is essential to decrease mortality among people with diabetes, but information is limited on how actual treatment relates to guidelines. We analysed changes in therapeutic approaches to anti‐hypertensive and lipid‐lowering medications in people with Type 2 diabetes from 2006 and 2015. Methods: Summary data from clinical services in seven countries outside North America and Western Europe were collected for 39 684 people. Each site summarized individual‐level data from outpatient medical records for 2006 and 2015. Data included: demographic information, blood pressure (BP), total cholesterol levels and percentage of people taking statins, anti‐hypertensive medication (angiotensin‐converting enzyme inhibitors, calcium channel blockers, angiotensin II receptor blockers, thiazide diuretics) and antiplatelet drugs. Results: From 2006 to 2015, mean cholesterol levels decreased in six of eight sites (range: −0.5 to −0.2), whereas the proportion with BP levels > 140/90 mmHg increased in seven of eight sites. Decreases in cholesterol paralleled increases in statin use (range: 3.1 to 47.0 percentage points). Overall, utilization of anti‐hypertensive medication did not change. However, there was an increase in the use of angiotensin II receptor blockers and a decrease in angiotensin‐converting enzyme inhibitors. The percentage of individuals receiving calcium channel blockers and aspirin remained unchanged. Conclusions: Our findings indicate that control of cholesterol levels improved and coincided with increased use of statins. The percentage of people with BP > 140/90 mmHg was higher in 2015 than in 2006. Hypertension treatment shifted from using angiotensin‐converting enzyme inhibitors to angiotensin II receptor blockers. Despite the potentially greater tolerability of angiotensin II receptor blockers, there was no associated improvement in BP levels. What's new?: Mean total cholesterol levels in people with diabetes decreased with a simultaneous increase in statin use.The percentage of people with blood pressure (BP) > 140/90 mmHg increased, which may reflect the change in BP targets from ≤ 130/80 to ≤ 140/90 mmHg that occurred between 2006 and 2015.Anti‐hypertensive treatment approaches shifted towards using more angiotensin II receptor blockers with a simultaneous decline in the use of angiotensin‐converting enzyme inhibitors.Although improved control of high cholesterol in people with diabetes was encouraging, further efforts are required to improve hypertension management in people with diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
16. Rationale and cross-sectional study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM study
- Author
-
Agyemang, C., Beune, E., Meeks, K., Owusu-Dabo, E., Agyei-Baffour, P., Aikins, A. d.-G., Dodoo, F., Smeeth, L., Addo, J., Mockenhaupt, F. P., Amoah, S. K., Schulze, M. B., Danquah, I., Spranger, J., Nicolaou, M., Klipstein-Grobusch, K., Burr, T., Henneman, P., Mannens, M. M., van Straalen, J. P., Bahendeka, S., Zwinderman, A. H., Kunst, A. E., Stronks, K., ACS - Amsterdam Cardiovascular Sciences, APH - Amsterdam Public Health, Public and occupational health, Graduate School, Human Genetics, AR&D - Amsterdam Reproduction & Development, Laboratory for General Clinical Chemistry, and Epidemiology and Data Science
- Subjects
Diabetes and Endocrinology ,Epidemiology ,Protocol - Abstract
INTRODUCTION: Obesity and type 2 diabetes (T2D) are highly prevalent among African migrants compared with European descent populations. The underlying reasons still remain a puzzle. Gene-environmental interaction is now seen as a potential plausible factor contributing to the high prevalence of obesity and T2D, but has not yet been investigated. The overall aim of the Research on Obesity and Diabetes among African Migrants (RODAM) project is to understand the reasons for the high prevalence of obesity and T2D among sub-Saharan Africans in diaspora by (1) studying the complex interplay between environment (eg, lifestyle), healthcare, biochemical and (epi)genetic factors, and their relative contributions to the high prevalence of obesity and T2D; (2) to identify specific risk factors within these broad categories to guide intervention programmes and (3) to provide a basic knowledge for improving diagnosis and treatment. METHODS AND ANALYSIS: RODAM is a multicentre cross-sectional study among homogenous sub-Saharan African participants (ie, Ghanaians) aged >25 years living in rural and urban Ghana, the Netherlands, Germany and the UK (http://rod-am.eu/). Standardised data on the main outcomes, genetic and non-genetic factors are collected in all locations. The aim is to recruit 6250 individuals comprising five subgroups of 1250 individuals from each site. In Ghana, Kumasi and Obuasi (urban stratum) and villages in the Ashanti region (rural stratum) are served as recruitment sites. In Europe, Ghanaian migrants are selected through the municipality or Ghanaian organisations registers. ETHICS AND DISSEMINATION: Ethical approval has been obtained in all sites. This paper gives an overview of the rationale, conceptual framework and methods of the study. The differences across locations will allow us to gain insight into genetic and non-genetic factors contributing to the occurrence of obesity and T2D and will inform targeted intervention and prevention programmes, and provide the basis for improving diagnosis and treatment in these populations and beyond.
- Published
- 2014
17. Development of Phenotypic and Genotypic Resistance to Antiretroviral Therapy in the UNAIDS HIV Drug Access Initiative -- Uganda [International Conference on AIDS (13th: 2000: Durban, South Africa)]
- Author
-
Weidle, PJ | Sozi, C. | Mwebaze, R. | Bahendeka, S. | Moss, V. | Rukondo, G. | Katabira, E. | Downing, R. | Hertogs, K. | Larder, B. | Respess, R. | Ochola, D. | Samb, B. | Lackritz, Eve, Weidle, PJ | Sozi, C. | Mwebaze, R. | Bahendeka, S. | Moss, V. | Rukondo, G. | Katabira, E. | Downing, R. | Hertogs, K. | Larder, B. | Respess, R. | Ochola, D. | Samb, B. | Lackritz, Eve, Weidle, PJ | Sozi, C. | Mwebaze, R. | Bahendeka, S. | Moss, V. | Rukondo, G. | Katabira, E. | Downing, R. | Hertogs, K. | Larder, B. | Respess, R. | Ochola, D. | Samb, B. | Lackritz, Eve, and Weidle, PJ | Sozi, C. | Mwebaze, R. | Bahendeka, S. | Moss, V. | Rukondo, G. | Katabira, E. | Downing, R. | Hertogs, K. | Larder, B. | Respess, R. | Ochola, D. | Samb, B. | Lackritz, Eve
- Abstract
(DLPS) 5571095.0156.026, http://name.umdl.umich.edu/5571095.0156.026, http://quod.lib.umich.edu/t/text/accesspolicy.html, Where applicable, subject to copyright. Other restrictions on distribution may apply. Please go to http://www.umdl.umich.edu/ for more information.
- Published
- 2000
18. Royal academy of medicine in ireland section of biological sciences: Proceedings of meeting held on 3rd January, 1986.
- Author
-
McLoughlin, P., McCaffrey, N., O’Regan, R. G., Hammad, M. K., Sheppard, B. L., Eaton, C., Bonnar, J., Whelan, J., Martin, F., Kane, M. T., Wilson, C. M., Dundee, J. W., Mathews, H. M. L., Moore, J., Feaklins, Roger, Andrews, J. F., Arbuthnott, E. R., Garvey, Eleanor, Bannigan, John, Hooper, A. C. B., Brien, T. G., Lawlor, P. G., Redmond, H. P., Redmond, J. M., Duignan, J. P., Waldron, D. J., Bowes, K. L., Given, H. F., O’Brien, Lorraine, Luckwill, R. G., Burke, M. C., McAvinchey, D., Waldron, R., Fitzpatrick, G. J., O’Malley, E., Ghaly, R. G., Lynas, A. G. A., Thompson, E. M., Fee, J. P. H., McClean, E., Carlisle, E. J. F., Kernohan, W. G., Allen, J. D., Bailey, A., Anderson, J., Adgey, A. A. J., Kennedy, M., Feely, S., Leek, B. F., Stafford, K. J., McCarron, J. G., Allen, J. M., Thornbury, K. D., McHale, N. G., Brady, H. R., Ryan, M. P., McDermott, Mary, Duenas-Laita, A., Barry, M. G., MacMathuna, P., Feely, J., Kelleher, P., Odumosu, A., Ganuza-Bidarte, M., Bell, P., McCaughey, W., Hawthorne, P., Bahendeka, S. K., Moore, R. E., Tobin, A. A. M., Barry, M., O’Reilly, T., Younger, K., Keeling, P. W. N., Harper, K. W., Collier, P. S., Collins, W. C. J., Cullen, M. J., McGirl, A., Dooley, E., Wilson, B. G., Odling-Smee, G. W., and Howard, P. J.
- Published
- 1986
- Full Text
- View/download PDF
19. Irish Endocrine Society Proceedings of Annual Meeting (The Professor D. A. D. Montgomery Meeting), Regional Hospital, Galway, October 10th–11th, 1986
- Author
-
McNicholl, J. M., O’Donnell, J., Greally, J. G., Carmody, E., Devlin, J., McKenna, T. J., Dolan, M., Clarke, H., Kirwan, A., Heffernan, A., Kennedy, A. L., Sheridan, B., Atkinson, A. B., Johnstone, H., Traub, A. I., Hoey, Hilary, Tanner, J. M., Cox, L. A., Smyth, P. P. A., Ritchie, C. M., Burgess, C., Kennedy, L., Hadden, D., Weaver, J., Atkinson, A. B., Sheridan, B., Clarke, George E., Kelleher, C., Grealy, G., Barry, D., Kingston, S. M., Ferriss, J. B., O’Sullivan, D. J., Cunningham, S. K., Sequeira, S. J., Chambers, J., McKenna, T. J., McCance, D. R., Hadden, D. R., Kennedy, L., Sheridan, B., Atkinson, A. B., McCance, D. R., Mcllrath, E., McNeill, A., Hadden, D. R., Kennedy, L., Sheridan, B., Atkinson, A. B., Collins, W., O’Connor, P., Cullen, M., Cranny, A., Feely, J., O’Meara, N., O’Donnell, L., Owens, D., Collins, P., Johnson, A., Tomkin, G., Stevens, A. B., Bell, P. M., Graham, A., Hayes, J. R., Bahendeka, S. K., Moore, R. E., Tomkin, G. H., Moles, K. W., McConnell, J. B., McCann, J. P., Buchanan, K. D., Lanigan, O., Powell, D., Atkinson, A. B., McAteer, E. J., Finlay, L., Hadden, D. R., Kennedy, A. L., Sheridan, B., Corcoran, A. E., Smyth, P. P. A., Sequeira, Savio J., Comiskey, G. A., McDermott, R., Powell, D., Frier, Brian M., and Ferriss, J. B.
- Published
- 1987
- Full Text
- View/download PDF
20. Royal Academy of Medicine in Ireland Section of Biological Sciences Proceedings of Summer Meeting, Trinity College Dublin Medical School, St. James’s Hospital, Dublin 8 on Thursday and Friday, 26th and 27th June, 1986
- Author
-
Chan, H. C., Cocoman, L., Feely, J., O’Connor, J. J., Rowan, M. J., Anwyl, R., McGuinness, S., Casey, P., Pratt, I., Mahon, E., O’Connor, C. M., Gebruers, E. M., Hall, W. J., Lordan, J. L., Felle, P., Harding, B., Meharg, M. K., McHale, N. G., Flynn, R., Ghaly, R. G., Wilson, C. M., McClean, E., Moore, J., Dundee, J. W., Guckian, Mary, Gallagher, R. B., van Breda, A., Fitzgerald, M. X., Feighery, C., McCall, Therese, Bloomfield, J., O’Leary, D., O’Morain, C. A., Alwan, Adel, McCann, S., Whelan, A., Bowe, Frances, West, Brian, Cafferkey, Mary, Uprichard, A. C. G., Allen, J. D., Harron, D. W. G., Furness, G., Milligan, K. R., O’Toole, D. P., Howe, J. P., Neville, Sharon, Rogers, Paquita, Allen, T. M., O’Briain, D. S., Cahill, P., Martin, F., McDaid, M., Kernan, R. P., Folan, Jean C., Hooper, A. C. B., Brien, T. G., Lardner, A., O’Donohoe, M. K., Yasear, A. Y., Moore, R. E., Arbuthnott, Elinor R., Sheppard, B. L., Sheppard, U., Harmon, K., Harrison, R. F., Jaff, M. S., Sweeney, E. C., Cullen, D., Hassan, Jaythoon, Bresnihan, B., Bahendeka, S. K., Tomkin, G. H., Buchanan, K. D., Buga, G. A. B., Kelly, M., Anwyl, Roger, Lee, Wai-Ling, Rowan, Michael, Maki, Amel, Thornbury, K. D., McCarron, J. G., Allen, J. M., McCullough, J. S., Moynihan, J. B., Breathnach, C. S., Power, Claire, Al-Arabi, A., Andrews, J. F., Dockeray, C. J., Daly, L., Bonnar, J., Jande, M. B., Sharma, S. C., Reynolds, Maura, McCann, Shaun R., Barron, D. W., McKay, A. C., Foster, J. C., Maxwell, W. J., Walsh, J. P., Hogan, F. P., Bloomfield, F. J., Kennedy, N. P., Keeling, P. W. N., Lynas, A. G. A., Clarke, R. S. J., Fee, J. P. H., Reid, J. E., Finegan, J., Evans, J., Abraham, D., and MacMathuna, P.
- Published
- 1987
- Full Text
- View/download PDF
21. I.4 Type II diabetes and obesity among sub-Saharan African native and migrant populations: dissection of environment and endogenous predisposition
- Author
-
Agyemang, C., primary, Beune, E., additional, Meeks, K., additional, Aikins, A. de-Graft, additional, and Bahendeka, S., additional
- Published
- 2014
- Full Text
- View/download PDF
22. Further experience in treating patients with hepatocellular carcinoma in Uganda.
- Author
-
Olweny, Charles L. M., Katongole-Mbidde, Edward, Bahendeka, Silver, Otim, David, Mugerwa, Jusua, Kyalwazi, Sebastian K., Olweny, C L, Katongole-Mbidde, E, Bahendeka, S, Otim, D, Mugerwa, J, and Kyalwazi, S K
- Published
- 1980
- Full Text
- View/download PDF
23. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
- Author
-
DART Trial Team, Mugyenyi, P, Walker, AS, Hakim, J, Munderi, P, Gibb, DM, Kityo, C, Reid, A, Grosskurth, H, Darbyshire, JH, Ssali, F, Bray, D, Katabira, E, Babiker, AG, Gilks, CF, Kabuye, G, Nsibambi, D, Kasirye, R, Zalwango, E, Nakazibwe, M, Kikaire, B, Nassuna, G, Massa, R, Fadhiru, K, Namyalo, M, Zalwango, A, Generous, L, Khauka, P, Rutikarayo, N, Nakahima, W, Mugisha, A, Todd, J, Levin, J, Muyingo, S, Ruberantwari, A, Kaleebu, P, Yirrell, D, Ndembi, N, Lyagoba, F, Hughes, P, Aber, M, Lara, A Medina, Foster, S, Amurwon, J, Wakholi, B Nyanzi, Whitworth, J, Wangati, K, Amuron, B, Kajungu, D, Nakiyingi, J, Omony, W, Tumukunde, D, Otim, T, Kabanda, J, Musana, H, Akao, J, Kyomugisha, H, Byamukama, A, Sabiiti, J, Komugyena, J, Wavamunno, P, Mukiibi, S, Drasiku, A, Byaruhanga, R, Labeja, O, Katundu, P, Tugume, S, Awio, P, Namazzi, A, Bakeinyaga, GT, Katabira, H, Abaine, D, Tukamushaba, J, Anywar, W, Ojiambo, W, Angweng, E, Murungi, S, Haguma, W, Atwiine, S, Kigozi, J, Namale, L, Mukose, A, Mulindwa, G, Atwiine, D, Muhwezi, A, Nimwesiga, E, Barungi, G, Takubwa, J, Mwebesa, D, Kagina, G, Mulindwa, M, Ahimbisibwe, F, Mwesigwa, P, Akuma, S, Zawedde, C, Nyiraguhirwa, D, Tumusiime, C, Bagaya, L, Namara, W, Karungi, J, Kankunda, R, Enzama, R, Latif, A, Robertson, V, Chidziva, E, Bulaya-Tembo, R, Musoro, G, Taziwa, F, Chimbetete, C, Chakonza, L, Mawora, A, Muvirimi, C, Tinago, G, Svovanapasis, P, Simango, M, Chirema, O, Machingura, J, Mutsai, S, Phiri, M, Bafana, T, Chirara, M, Muchabaiwa, L, Muzambi, M, Mutowo, J, Chivhunga, T, Chigwedere, E, Pascoe, M, Warambwa, C, Zengeza, E, Mapinge, F, Makota, S, Jamu, A, Ngorima, N, Chirairo, H, Chitsungo, S, Chimanzi, J, Maweni, C, Warara, R, Matongo, M, Mudzingwa, S, Jangano, M, Moyo, K, Vere, L, Mdege, N, Machingura, I, Ronald, A, Kambungu, A, Lutwama, F, Mambule, I, Nanfuka, A, Walusimbi, J, Nabankema, E, Nalumenya, R, Namuli, T, Kulume, R, Namata, I, Nyachwo, L, Florence, A, Kusiima, A, Lubwama, E, Nairuba, R, Oketta, F, Buluma, E, Waita, R, Ojiambo, H, Sadik, F, Wanyama, J, Nabongo, P, Oyugi, J, Sematala, F, Muganzi, A, Twijukye, C, Byakwaga, H, Ochai, R, Muhweezi, D, Coutinho, A, Etukoit, B, Gilks, C, Boocock, K, Puddephatt, C, Grundy, C, Bohannon, J, Winogron, D, Burke, A, Babiker, A, Wilkes, H, Rauchenberger, M, Sheehan, S, Spencer-Drake, C, Taylor, K, Spyer, M, Ferrier, A, Naidoo, B, Dunn, D, Goodall, R, Peto, L, Nanfuka, R, Mufuka-Kapuya, C, Pillay, D, McCormick, A, Weller, I, Bahendeka, S, Bassett, M, Wapakhabulo, A Chogo, Gazzard, B, Mapuchere, C, Mugurungi, O, Burke, C, Jones, S, Newland, C, Pearce, G, Rahim, S, Rooney, J, Smith, M, Snowden, W, Steens, J-M, Breckenridge, A, McLaren, A, Hill, C, Matenga, J, Pozniak, A, Serwadda, D, Peto, T, Palfreeman, A, and Borok, M
- Subjects
Male ,Neutrophils ,HIV Infections ,law.invention ,Hemoglobins ,Randomized controlled trial ,law ,Medicine ,Urea ,HIV-Associated Lipodystrophy Syndrome ,Hazard ratio ,Lamivudine ,Anemia ,General Medicine ,Middle Aged ,Viral Load ,Anti-Retroviral Agents ,Creatinine ,Disease Progression ,RNA, Viral ,Female ,Drug Monitoring ,Zidovudine ,medicine.drug ,Glomerular Filtration Rate ,Adult ,medicine.medical_specialty ,Neutropenia ,Adolescent ,Organophosphonates ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,Fast track — Articles ,Humans ,Nevirapine ,Adverse effect ,Tenofovir ,Aged ,Intention-to-treat analysis ,business.industry ,Adenine ,medicine.disease ,Dideoxynucleosides ,CD4 Lymphocyte Count ,Clinical trial ,Clinical research ,Immunology ,Africa ,HIV-1 ,business - Abstract
BACKGROUND: HIV antiretroviral therapy (ART) is often managed without routine laboratory monitoring in Africa; however, the effect of this approach is unknown. This trial investigated whether routine toxicity and efficacy monitoring of HIV-infected patients receiving ART had an important long-term effect on clinical outcomes in Africa. METHODS: In this open, non-inferiority trial in three centres in Uganda and one in Zimbabwe, 3321 symptomatic, ART-naive, HIV-infected adults with CD4 counts less than 200 cells per microL starting ART were randomly assigned to laboratory and clinical monitoring (LCM; n=1659) or clinically driven monitoring (CDM; n=1662) by a computer-generated list. Haematology, biochemistry, and CD4-cell counts were done every 12 weeks. In the LCM group, results were available to clinicians; in the CDM group, results (apart from CD4-cell count) could be requested if clinically indicated and grade 4 toxicities were available. Participants switched to second-line ART after new or recurrent WHO stage 4 events in both groups, or CD4 count less than 100 cells per microL (LCM only). Co-primary endpoints were new WHO stage 4 HIV events or death, and serious adverse events. Non-inferiority was defined as the upper 95% confidence limit for the hazard ratio (HR) for new WHO stage 4 events or death being no greater than 1.18. Analyses were by intention to treat. This study is registered, number ISRCTN13968779. FINDINGS: Two participants assigned to CDM and three to LCM were excluded from analyses. 5-year survival was 87% (95% CI 85-88) in the CDM group and 90% (88-91) in the LCM group, and 122 (7%) and 112 (7%) participants, respectively, were lost to follow-up over median 4.9 years' follow-up. 459 (28%) participants receiving CDM versus 356 (21%) LCM had a new WHO stage 4 event or died (6.94 [95% CI 6.33-7.60] vs 5.24 [4.72-5.81] per 100 person-years; absolute difference 1.70 per 100 person-years [0.87-2.54]; HR 1.31 [1.14-1.51]; p=0.0001). Differences in disease progression occurred from the third year on ART, whereas higher rates of switch to second-line treatment occurred in LCM from the second year. 283 (17%) participants receiving CDM versus 260 (16%) LCM had a new serious adverse event (HR 1.12 [0.94-1.32]; p=0.19), with anaemia the most common (76 vs 61 cases). INTERPRETATION: ART can be delivered safely without routine laboratory monitoring for toxic effects, but differences in disease progression suggest a role for monitoring of CD4-cell count from the second year of ART to guide the switch to second-line treatment. FUNDING: UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.
- Full Text
- View/download PDF
24. Impact of second-line antiretroviral regimens on lipid profiles in an African setting: The DART trial sub-study
- Author
-
Gomo, Z. A. R., Hakim, J. G., Walker, S. A., Tinago, W., Mandozana, G., Kityo, C., Munderi, P., Katabira, E., Reid, A., Gibb, D. M., Gilks, C. F., Grosskurth, H., Kabuye, G., Nsibambi, D., Kasirye, R., Zalwango, E., Nakazibwe, M., Kikaire, B., Nassuna, G., Massa, R., Fadhiru, K., Namyalo, M., Zalwango, A., Generous, L., Khauka, P., Rutikarayo, N., Nakahima, W., Mugisha, A., Todd, J., Levin, J., Muyingo, S., Ruberantwari, A., Kaleebu, P., Yirrell, D., Ndembi, N., Lyagoba, F., Hughes, P., Aber, M., Lara, A. M., Medina, A., Foster, S., Amurwon, J., Wakholi, B. N., Nyanzi, B., Wangati, K., Amuron, B., Kajungu, D., Nakiyingi, J., Omony, W., Mugyenyi, P., Ssali, F., Tumukunde, D., Otim, T., Kabanda, J., Musana, H., Akao, J., Kyomugisha, H., Byamukama, A., Sabiiti, J., Komugyena, J., Wavamunno, P., Mukiibi, S., Drasiku, A., Byaruhanga, R., Labeja, O., Katundu, P., Tugume, S., Awio, P., Namazzi, A., Bakeinyaga, G. T., Abaine, D., Tukamushaba, J., Anywar, W., Ojiambo, W., Angweng, E., Murungi, S., Haguma, W., Atwiine, S., Kigozi, J., Namale, L., Mukose, A., Mulindwa, G., Atwiine, D., Muhwezi, A., Nimwesiga, E., Barungi, G., Takubwa, J., Mwebesa, D., Kagina, G., Mulindwa, M., Ahimbisibwe, F., Mwesigwa, P., Akuma, S., Zawedde, C., Nyiraguhirwa, D., Tumusiime, C., Bagaya, L., Namara, W., Karungi, J., Kankunda, R., Enzama, R., Latif, A., Robertson, V., Chidziva, E., Bulaya-Tembo, R., Musoro, G., Taziwa, F., Chimbetete, C., Chakonza, L., Mawora, A., Muvirimi, C., Svovanapasis, P., Simango, M., Chirema, O., Machingura, J., Mutsai, S., Phiri, M., Bafana, T., Chirara, M., Muchabaiwa, L., Muzambi, M., Chigwedere, E., Pascoe, M., Warambwa, C., Zengeza, E., Mapinge, F., Makota, S., Jamu, A., Ngorima, N., Chirairo, H., Chitsungo, S., Chimanzi, J., Maweni, C., Warara, R., Matongo, M., Mudzingwa, S., Jangano, M., Moyo, K., Vere, L., Machingura, I., Ronald, A., Kambungu, A., Lutwama, F., Mambule, I., Nanfuka, A., Walusimbi, J., Nabankema, E., Nalumenya, R., Namuli, T., Kulume, R., Namata, I., Nyachwo, L., Florence, A., Kusiima, A., Lubwama, E., Nairuba, R., Oketta, F., Buluma, E., Waita, R., Ojiambo, H., Sadik, F., Wanyama, J., Nabongo, P., Oyugi, J., Sematala, F., Muganzi, A., Twijukye, C., Byakwaga, H., Ochai, R., Muhweezi, D., Coutinho, A., Etukoit, B., Boocock, K., Puddephatt, C., Grundy, C., Bohannon, J., Winogron, D., Darbyshire, J., Burke, A., Bray, D., Babiker, A., Wilkes, H., Rauchenberger, M., Sheehan, S., Spencer-Drake, C., Taylor, K., Spyer, M., Ferrier, A., Naidoo, B., Dunn, D., Ruth Goodall, Nanfuka, R., Mufuka-Kapuya, C., Pillay, D., Goodall, R., Kapaata, A., Katuramur, M., Magala, R., Magambo, B., Mataruka, K., Mccormick, A., Mugarura, L., Musunga, T., Nabankkema, M., Nkalubo, J., Nkurunziza, P., Parry, C., Weller, I., Bahendeka, S., Bassett, M., Chogo Wapakhabulo, A., Gazzard, B., Mapuchere, C., Mugurungi, O., Burke, C., Distel, M., Jones, S., Loeliger, E., Naidoo, P., Newland, C., Pearce, G., Rahim, S., Rooney, J., Smith, M., Snowden, W., Steens, J. -M, Breckenridge, A., Mclaren, A., Hill, C., Matenga, J., Pozniak, A., Serwadda, D., Peto, T., Palfreeman, A., and Borok, M.
25. Gestational diabetes mellitus: Berlin and beyond
- Author
-
Kalra, S., Coetzee, A., Afsana, F., Aye, T. T., Bahendeka, S., Bajaj, S., Bashir, M., Chaudhary, S., Das, A. K., Farooqi, M. H., Jawad, F., Jimeno, C., Latif, Z. A., Latt, T. S., Rayaz Malik, Pathan, M. F., Raza, S. A., Shimjee, S., Shrestha, D., Somasundaram, N., and Uloko, A. E.
26. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study
- Author
-
Lloyd, C. E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, A., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U., van Dam, K., Vukovic, O., Wölwer, W., Lloyd, C. E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, A., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U., van Dam, K., Vukovic, O., and Wölwer, W.
- Abstract
Aims: To examine the factors that are associated with changes in depression in people with type 2 diabetes living in 12 different countries. Methods: People with type 2 diabetes treated in out-patient settings aged 18-65 years underwent a psychiatric assessment to diagnose major depressive disorder (MDD) at baseline and follow-up. At both time points, participants completed the Patient Health Questionnaire (PHQ-9), the WHO five-item Well-being scale (WHO-5) and the Problem Areas in Diabetes (PAID) scale which measures diabetes-related distress. A composite stress score (CSS) (the occurrence of stressful life events and their reported degree of 'upset') between baseline and follow-up was calculated. Demographic data and medical record information were collected. Separate regression analyses were conducted with MDD and PHQ-9 scores as the dependent variables. Results: In total, there were 7.4% (120) incident cases of MDD with 81.5% (1317) continuing to remain free of a diagnosis of MDD. Univariate analyses demonstrated that those with MDD were more likely to be female, less likely to be physically active, more likely to have diabetes complications at baseline and have higher CSS. Mean scores for the WHO-5, PAID and PHQ-9 were poorer in those with incident MDD compared with those who had never had a diagnosis of MDD. Regression analyses demonstrated that higher PHQ-9, lower WHO-5 scores and greater CSS were significant predictors of incident MDD. Significant predictors of PHQ-9 were baseline PHQ-9 score, WHO-5, PAID and CSS. Conclusion: This study demonstrates the importance of psychosocial factors in addition to physiological variables in the development of depressive symptoms and incident MDD in people with type 2 diabetes. Stressful life events, depressive symptoms and diabetes-related distress all play a significant role which has implications for practice. A more holistic approach to care, which recognises the interplay of these psychosocial factors, may help to m
27. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study
- Author
-
Lloyd, C. E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, A., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U., van Dam, K., Vukovic, O., Wölwer, W., Lloyd, C. E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, A., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U., van Dam, K., Vukovic, O., and Wölwer, W.
- Abstract
Aims: To examine the factors that are associated with changes in depression in people with type 2 diabetes living in 12 different countries. Methods: People with type 2 diabetes treated in out-patient settings aged 18-65 years underwent a psychiatric assessment to diagnose major depressive disorder (MDD) at baseline and follow-up. At both time points, participants completed the Patient Health Questionnaire (PHQ-9), the WHO five-item Well-being scale (WHO-5) and the Problem Areas in Diabetes (PAID) scale which measures diabetes-related distress. A composite stress score (CSS) (the occurrence of stressful life events and their reported degree of 'upset') between baseline and follow-up was calculated. Demographic data and medical record information were collected. Separate regression analyses were conducted with MDD and PHQ-9 scores as the dependent variables. Results: In total, there were 7.4% (120) incident cases of MDD with 81.5% (1317) continuing to remain free of a diagnosis of MDD. Univariate analyses demonstrated that those with MDD were more likely to be female, less likely to be physically active, more likely to have diabetes complications at baseline and have higher CSS. Mean scores for the WHO-5, PAID and PHQ-9 were poorer in those with incident MDD compared with those who had never had a diagnosis of MDD. Regression analyses demonstrated that higher PHQ-9, lower WHO-5 scores and greater CSS were significant predictors of incident MDD. Significant predictors of PHQ-9 were baseline PHQ-9 score, WHO-5, PAID and CSS. Conclusion: This study demonstrates the importance of psychosocial factors in addition to physiological variables in the development of depressive symptoms and incident MDD in people with type 2 diabetes. Stressful life events, depressive symptoms and diabetes-related distress all play a significant role which has implications for practice. A more holistic approach to care, which recognises the interplay of these psychosocial factors, may help to m
28. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries
- Author
-
Lloyd, C. E., Nouwen, A., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Basangwa, D., Boborov, A. E., Boden, S., Bulgari, V., Burti, L., Chaturvedi, S. K., Cimino, L. C., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg de Braude, M., Guntupalli, A., Heinze, M. G., Ji, L., Hong, X., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic Tosevski, D., Mankovsky, B., Li, M., Musau, A., Mussig, K., Ndetei, D., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Vukovic, O., Wolwer, W., Xin, Y., Lloyd, C. E., Nouwen, A., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Basangwa, D., Boborov, A. E., Boden, S., Bulgari, V., Burti, L., Chaturvedi, S. K., Cimino, L. C., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg de Braude, M., Guntupalli, A., Heinze, M. G., Ji, L., Hong, X., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic Tosevski, D., Mankovsky, B., Li, M., Musau, A., Mussig, K., Ndetei, D., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Vukovic, O., Wolwer, W., and Xin, Y.
- Abstract
Aims To assess the prevalence and management of depressive disorders in people with Type 2 diabetes in different countries. Methods People with diabetes aged 18–65 years and treated in outpatient settings were recruited in 14 countries and underwent a psychiatric interview. Participants completed the Patient Health Questionnaire and the Problem Areas in Diabetes scale. Demographic and medical record data were collected. Results A total of 2783 people with Type 2 diabetes (45.3% men, mean duration of diabetes 8.8 years) participated. Overall, 10.6% were diagnosed with current major depressive disorder and 17.0% reported moderate to severe levels of depressive symptomatology (Patient Health Questionnaire scores >9). Multivariable analyses showed that, after controlling for country, current major depressive disorder was significantly associated with gender (women) (P<0.0001), a lower level of education (P<0.05), doing less exercise (P<0.01), higher levels of diabetes distress (P<0.0001) and a previous diagnosis of major depressive disorder (P<0.0001). The proportion of those with either current major depressive disorder or moderate to severe levels of depressive symptomatology who had a diagnosis or any treatment for their depression recorded in their medical records was extremely low and non-existent in many countries (0–29.6%). Conclusions Our international study, the largest of this type ever undertaken, shows that people with diabetes frequently have depressive disorders and also significant levels of depressive symptoms. Our findings indicate that the identification and appropriate care for psychological and psychiatric problems is not the norm and suggest a lack of the comprehensive approach to diabetes management that is needed to improve clinical outcomes.
29. A multi-dimensional Sustainable Diet Index (SDI) for Ghanaian adults under transition: the RODAM Study.
- Author
-
Okekunle AP, Nicolaou M, De Allegri M, Meeks KAC, Osei-Kwasi H, Stockemer J, de-Graft Aikins A, Agbemafle I, Bahendeka S, Boateng D, Klipstein-Grobusch K, Beune E, Agyemang C, Schulze MB, and Danquah I
- Subjects
- Humans, Ghana, Female, Middle Aged, Male, Adult, Cross-Sectional Studies, Aged, Socioeconomic Factors, Urban Population statistics & numerical data, Diet, Healthy statistics & numerical data, Diet, Healthy methods, Diet methods, Diet statistics & numerical data, Transients and Migrants statistics & numerical data, Life Style, Rural Population statistics & numerical data
- Abstract
Background: The sustainability of diets consumed by African populations under socio-economic transition remains to be determined. This study developed and characterized a multi-dimensional Sustainable Diet Index (SDI) reflecting healthfulness, climate-friendliness, sociocultural benefits, and financial affordability using individual-level data of adults in rural and urban Ghana and Ghanaian migrants in Europe to identify the role of living environment in dietary sustainability., Methods: We used cross-sectional data from the multi-centre Research on Obesity and Diabetes among African Migrants Study (N = 3169; age range: 25-70 years). For the SDI construct (0-16 score points), we used the Diet Quality Index-International, food-related greenhouse gas emission, the ratio of natural to processed foods, and the proportion of food expenditure from income. In linear regression analyses, we estimated the adjusted ß-coefficients and 95% confidence intervals (CIs) for the differences in mean SDI across study sites (using rural Ghana as a reference), accounting for sociodemographic and lifestyle factors., Results: The overall mean SDI was 8.0 (95% CI: 7.9, 8.1). Participants in the highest SDI-quintile compared to lower quintiles were older, more often women, non-smokers, and alcohol abstainers. The highest mean SDI was seen in London (9.1; 95% CI: 8.9, 9.3), followed by rural Ghana (8.2; 95% CI: 8.0, 8.3), Amsterdam (7.9; 95% CI: 7.7, 8.1), Berlin (7.8; 95% CI: 7.6, 8.0), and urban Ghana (7.7; 95% CI: 7.5, 7.8). Compared to rural Ghana, the differences between study sites were attenuated after accounting for age, gender and energy intake. No further changes were observed after adjustment for lifestyle factors., Conclusion: The multi-dimensional SDI describes four dimensions of dietary sustainability in this Ghanaian population. Our findings suggest that living in Europe improved dietary sustainability, but the opposite seems true for urbanization in Ghana., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review.
- Author
-
Sseguya W, Bahendeka S, MacLennan S, Mody N, and Guntupalli AM
- Subjects
- Humans, Africa South of the Sahara epidemiology, Hospitalization statistics & numerical data, SARS-CoV-2, COVID-19 epidemiology, Diabetes Mellitus epidemiology, Pandemics
- Abstract
Background: The COVID-19 pandemic impacted the healthcare and outcomes of individuals with various chronic diseases. However, there is a paucity of data on the impact of the COVID-19 pandemic on diabetes mellitus (DM) in low-resource settings. To address this, we conducted a scoping review to explore the literature published on diabetes-related COVID-19 outcomes and care during the COVID-19 pandemic in countries of sub-Saharan Africa., Methods: We applied our search strategy to PubMed, Web of Science, CINAHL, African Index Medicus, Google Scholar, Cochrane Library, Scopus, Science Direct, ERIC and Embase to obtain relevant articles published from January 2020 to March 2023. Two independent reviewers were involved in screening the retrieved articles. Data from eligible articles were extracted from quantitative, qualitative and mixed-methods studies. Quantitative evidence was summarised using descriptive statistics, while a thematic framework was used to identify and categorise themes from qualitative evidence., Results: We found 42 of the retrieved 360 articles eligible, mainly from South Africa, Ethiopia and Ghana (73.4%). The incidence of DM among COVID-19 cases was 13.7/1,000 person-days observation. COVID-19 was associated with increased odds of death (OR 1.30-9.0, 95% CI), hospitalisation (OR 3.30-3.73: 95% CI), and severity (OR: 1.30-4.05, 95% CI) in persons with DM. Challenges in caring for DM during the pandemic were inadequate patient self-management, difficulties in healthcare access, and inadequate healthcare resources., Conclusion: The COVID-19 pandemic was characterised by a high incidence of DM in persons infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and high COVID-19-associated mortality, severity, and hospitalisation among people persons with DM. The pandemic also created difficulties in DM self-management and worsened the quality of DM care services. Policymakers should devise preventive and management strategies for DM during emerging and re-emerging infectious disease epidemics and outbreaks, given that such occurrences are increasingly frequent in the region., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Sseguya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
31. Effectiveness of a nurse-led management intervention on systolic blood pressure among type 2 diabetes patients in Uganda: a cluster randomized trial.
- Author
-
Lumu W, Bahendeka S, Kibirige D, Wesonga R, and Mutebi RK
- Abstract
Background: Hypertension (HT) is an orchestrator of atherosclerotic cardiovascular disease (ASCVD) in people living with type 2 diabetes (T2D). Control of systolic blood pressure (SBP) and HT as a whole is suboptimal in diabetes, partly due to the scarcity of doctors. While nurse-led interventions are pragmatic and cost-effective in the control of HT in primary health care, their effectiveness on SBP control among patients with T2D in Uganda is scantly known., Aim: We evaluated the effectiveness of a nurse-led management intervention on SBP among T2D patients with a high ASCVD risk in Uganda., Methods: A two-armed cluster randomized controlled trial compared the nurse-led management intervention with usual doctor-led care. The intervention involved training nurses to provide structured health education, protocol-based HT/CVD management, 24-h phone calls, and 2-monthly text messages for 6 months. The primary outcome was the mean difference in SBP change among patients with T2D with a high ASCVD risk in the intervention and control groups after 6 months. The secondary outcome was the absolute difference in the number of patients at target for SBP, total cholesterol (TC), fasting blood glucose (FBG), glycated hemoglobin (HbA1C), low-density lipoprotein (LDL), triglycerides (TG), and body mass index (BMI) after the intervention. The study was analyzed according to the intention-to-treat principle. Generalized estimating equations were used to assess intra-cluster effect modifiers. Statistical significance was set at 0.05 for all analyses., Results: Eight clinics (n = 388 patients) were included (intervention 4 clinics; n = 192; control 4 clinics; n = 196). A nurse-led intervention reduced SBP by -11.21 ± 16.02 mmHg with a mean difference between the groups of -13.75 mmHg (95% CI -16.48 to -11.02, p < 0.001). An increase in SBP of 2.54 ± 10.95 mmHg was observed in the control group. Diastolic blood pressure was reduced by -6.80 ± 9.48 mmHg with a mean difference between groups of -7.20 mmHg (95% C1 -8.87 to -5.48, p < 0.001). The mean differences in the change in ASCVD score and glycated hemoglobin were -4.73% (95% CI -5.95 to -3.51, p = 0.006) and -0.82% (95% CI -1.30 to -0.35, p = 0.001), respectively. There were significant absolute differences in the number of patients at target in SBP (p = 0.001), DBP (p = 0.003), and TC (p = 0.008)., Conclusion: A nurse-led management intervention reduces SBP and ASCVD risk among patients with T2D. Such an intervention may be pragmatic in the screening and management of HT/ASCVD in Uganda., Trial Registration: Pan African Clinical Trial Registry, PACTR202001916873358, registered on 6th October 2019., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. Multiple cardiovascular risk factor care in 55 low- and middle-income countries: A cross-sectional analysis of nationally-representative, individual-level data from 280,783 adults.
- Author
-
Diallo AO, Marcus ME, Flood D, Theilmann M, Rahim NE, Kinlaw A, Franceschini N, Stürmer T, Tien DV, Abbasi-Kangevari M, Agoudavi K, Andall-Brereton G, Aryal K, Bahendeka S, Bicaba B, Bovet P, Dorobantu M, Farzadfar F, Ghamari SH, Gathecha G, Guwatudde D, Gurung M, Houehanou C, Houinato D, Hwalla N, Jorgensen J, Kagaruki G, Karki K, Martins J, Mayige M, McClure RW, Moghaddam SS, Mwalim O, Mwangi KJ, Norov B, Quesnel-Crooks S, Sibai A, Sturua L, Tsabedze L, Wesseh C, Geldsetzer P, Atun R, Vollmer S, Bärnighausen T, Davies J, Ali MK, Seiglie JA, Gower EW, and Manne-Goehler J
- Abstract
The prevalence of multiple age-related cardiovascular disease (CVD) risk factors is high among individuals living in low- and middle-income countries. We described receipt of healthcare services for and management of hypertension and diabetes among individuals living with these conditions using individual-level data from 55 nationally representative population-based surveys (2009-2019) with measured blood pressure (BP) and diabetes biomarker. We restricted our analysis to non-pregnant individuals aged 40-69 years and defined three mutually exclusive groups (i.e., hypertension only, diabetes only, and both hypertension-diabetes) to compare individuals living with concurrent hypertension and diabetes to individuals with each condition separately. We included 90,086 individuals who lived with hypertension only, 11,975 with diabetes only, and 16,228 with hypertension-diabetes. We estimated the percentage of individuals who were aware of their diagnosis, used pharmacological therapy, or achieved appropriate hypertension and diabetes management. A greater percentage of individuals with hypertension-diabetes were fully diagnosed (64.1% [95% CI: 61.8-66.4]) than those with hypertension only (47.4% [45.3-49.6]) or diabetes only (46.7% [44.1-49.2]). Among the hypertension-diabetes group, pharmacological treatment was higher for individual conditions (38.3% [95% CI: 34.8-41.8] using antihypertensive and 42.3% [95% CI: 39.4-45.2] using glucose-lowering medications) than for both conditions jointly (24.6% [95% CI: 22.1-27.2]).The percentage of individuals achieving appropriate management was highest in the hypertension group (17.6% [16.4-18.8]), followed by diabetes (13.3% [10.7-15.8]) and hypertension-diabetes (6.6% [5.4-7.8]) groups. Although health systems in LMICs are reaching a larger share of individuals living with both hypertension and diabetes than those living with just one of these conditions, only seven percent achieved both BP and blood glucose treatment targets. Implementation of cost-effective population-level interventions that shift clinical care paradigm from disease-specific to comprehensive CVD care are urgently needed for all three groups, especially for those with multiple CVD risk factors., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Diallo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
33. Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries.
- Author
-
Stein DT, Reitsma MB, Geldsetzer P, Agoudavi K, Aryal KK, Bahendeka S, Brant LCC, Farzadfar F, Gurung MS, Guwatudde D, Houehanou YCN, Malta DC, Martins JS, Saeedi Moghaddam S, Mwangi KJ, Norov B, Sturua L, Zhumadilov Z, Bärnighausen T, Davies JI, Flood D, Marcus ME, Theilmann M, Vollmer S, Manne-Goehler J, Atun R, Sudharsanan N, and Verguet S
- Subjects
- Humans, Developing Countries, Cross-Sectional Studies, Cardiovascular Diseases epidemiology, Cardiovascular Diseases therapy, Hypertension diagnosis, Hypertension drug therapy, Hypertension epidemiology
- Abstract
Improving hypertension control in low- and middle-income countries has uncertain implications across socioeconomic groups. In this study, we simulated improvements in the hypertension care cascade and evaluated the distributional benefits across wealth quintiles in 44 low- and middle-income countries using individual-level data from nationally representative, cross-sectional surveys. We raised diagnosis (diagnosis scenario) and treatment (treatment scenario) levels for all wealth quintiles to match the best-performing country quintile and estimated the change in 10-year cardiovascular disease (CVD) risk of individuals initiated on treatment. We observed greater health benefits among bottom wealth quintiles in middle-income countries and in countries with larger baseline disparities in hypertension management. Lower-middle-income countries would see the greatest absolute benefits among the bottom quintiles under the treatment scenario (29.1 CVD cases averted per 1,000 people living with hypertension in the bottom quintile (Q1) versus 17.2 in the top quintile (Q5)), and the proportion of total CVD cases averted would be largest among the lowest quintiles in upper-middle-income countries under both diagnosis (32.0% of averted cases in Q1 versus 11.9% in Q5) and treatment (29.7% of averted cases in Q1 versus 14.0% in Q5) scenarios. Targeted improvements in hypertension diagnosis and treatment could substantially reduce socioeconomic-based inequalities in CVD burden in low- and middle-income countries., (© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
34. Validation of prevalent diabetes risk scores based on non-invasively measured predictors in Ghanaian migrant and non-migrant populations - The RODAM study.
- Author
-
Osei-Yeboah J, Kengne AP, Owusu-Dabo E, Schulze MB, Meeks KAC, Klipstein-Grobusch K, Smeeth L, Bahendeka S, Beune E, Moll van Charante EP, and Agyemang C
- Abstract
Background: Non-invasive diabetes risk models are a cost-effective tool in large-scale population screening to identify those who need confirmation tests, especially in resource-limited settings., Aims: This study aimed to evaluate the ability of six non-invasive risk models (Cambridge, FINDRISC, Kuwaiti, Omani, Rotterdam, and SUNSET model) to identify screen-detected diabetes (defined by HbA1c) among Ghanaian migrants and non-migrants., Study Design: A multicentered cross-sectional study., Methods: This analysis included 4843 Ghanaian migrants and non-migrants from the Research on Obesity and Diabetes among African Migrants (RODAM) Study. Model performance was assessed using the area under the receiver operating characteristic curves (AUC), Hosmer-Lemeshow statistics, and calibration plots., Results: All six models had acceptable discrimination (0.70 ≤ AUC <0.80) for screen-detected diabetes in the overall/combined population. Model performance did not significantly differ except for the Cambridge model, which outperformed Rotterdam and Omani models. Calibration was poor, with a consistent trend toward risk overestimation for screen-detected diabetes, but this was substantially attenuated by recalibration through adjustment of the original model intercept., Conclusion: Though acceptable discrimination was observed, the original models were poorly calibrated among populations of African ancestry. Recalibration of these models among populations of African ancestry is needed before use., Competing Interests: By letter the authors declare no competing interests. And that all funding sources for this work have been declared., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
35. Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data.
- Author
-
Rahim NE, Flood D, Marcus ME, Theilmann M, Aung TN, Agoudavi K, Aryal KK, Bahendeka S, Bicaba B, Bovet P, Diallo AO, Farzadfar F, Guwatudde D, Houehanou C, Houinato D, Hwalla N, Jorgensen J, Kagaruki GB, Mayige M, Wong-McClure R, Larijani B, Saeedi Moghaddam S, Mwalim O, Mwangi KJ, Sarkar S, Sibai AM, Sturua L, Wesseh C, Geldsetzer P, Atun R, Vollmer S, Bärnighausen T, Davies J, Ali MK, Seiglie JA, and Manne-Goehler J
- Subjects
- Adult, Female, Humans, Male, Pregnancy, Blood Glucose, Cross-Sectional Studies, Developing Countries, Weight Loss, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 prevention & control
- Abstract
Background: The global burden of diabetes is rising rapidly, yet there is little evidence on individual-level diabetes prevention activities undertaken by health systems in low-income and middle-income countries (LMICs). Here we describe the population at high risk of developing diabetes, estimate diabetes prevention activities, and explore sociodemographic variation in these activities across LMICs., Methods: We performed a pooled, cross-sectional analysis of individual-level data from nationally representative, population-based surveys conducted in 44 LMICs between October, 2009, and May, 2019. Our sample included all participants older than 25 years who did not have diabetes and were not pregnant. We defined the population at high risk of diabetes on the basis of either the presence of impaired fasting glucose (or prediabetes in countries with a haemoglobin A
1c available) or overweight or obesity, consistent with the WHO Package of Essential Noncommunicable Disease Guidelines for type 2 diabetes management. We estimated the proportion of survey participants that were at high risk of developing diabetes based on this definition. We also estimated the proportion of the population at high risk that reported each of four fundamental diabetes prevention activities: physical activity counselling, weight loss counselling, dietary counselling, and blood glucose screening, overall and stratified by World Bank income group. Finally, we used multivariable Poisson regression models to evaluate associations between sociodemographic characteristics and these activities., Findings: The final pooled sample included 145 739 adults (86 269 [59·2%] of whom were female and 59 468 [40·4%] of whom were male) across 44 LMICs, of whom 59 308 (40·6% [95% CI 38·5-42·8]) were considered at high risk of diabetes (20·6% [19·8-21·5] in low-income countries, 38·0% [37·2-38·9] in lower-middle-income countries, and 57·5% [54·3-60·6] in upper-middle-income countries). Overall, the reach of diabetes prevention activities was low at 40·0% (38·6-41·4) for physical activity counselling, 37·1% (35·9-38·4) for weight loss counselling, 42·7% (41·6-43·7) for dietary counselling, and 37·1% (34·7-39·6) for blood glucose screening. Diabetes prevention varied widely by national-level wealth: 68·1% (64·6-71·4) of people at high risk of diabetes in low-income countries reported none of these activities, whereas 49·0% (47·4-50·7) at high risk in upper-middle-income countries reported at least three activities. Educational attainment was associated with diabetes prevention, with estimated increases in the predicted probability of receipt ranging between 6·5 (3·6-9·4) percentage points for dietary fruit and vegetable counselling and 21·3 (19·5-23·2) percentage points for blood glucose screening, among people with some secondary schooling compared with people with no formal education., Interpretation: A large proportion of individuals across LMICs are at high risk of diabetes but less than half reported receiving fundamental prevention activities overall, with the lowest receipt of these activities among people in low-income countries and with no formal education. These findings offer foundational evidence to inform future global targets for diabetes prevention and to strengthen policies and programmes to prevent continued increases in diabetes worldwide., Funding: Harvard T H Chan School of Public Health McLennan Fund: Dean's Challenge Grant Program and the EU's Research and Innovation programme Horizon 2020., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
36. Diagnostic testing for hypertension, diabetes, and hypercholesterolaemia in low-income and middle-income countries: a cross-sectional study of data for 994 185 individuals from 57 nationally representative surveys.
- Author
-
Ochmann S, von Polenz I, Marcus ME, Theilmann M, Flood D, Agoudavi K, Aryal KK, Bahendeka S, Bicaba B, Bovet P, Campos Caldeira Brant L, Carvalho Malta D, Damasceno A, Farzadfar F, Gathecha G, Ghanbari A, Gurung M, Guwatudde D, Houehanou C, Houinato D, Hwalla N, Jorgensen JA, Karki KB, Lunet N, Martins J, Mayige M, Moghaddam SS, Mwalim O, Mwangi KJ, Norov B, Quesnel-Crooks S, Rezaei N, Sibai AM, Sturua L, Tsabedze L, Wong-McClure R, Davies J, Geldsetzer P, Bärnighausen T, Atun R, Manne-Goehler J, and Vollmer S
- Subjects
- United States, Adult, Male, Female, Humans, Cross-Sectional Studies, Developing Countries, Diagnostic Techniques and Procedures, Hypercholesterolemia diagnosis, Hypercholesterolemia epidemiology, Diabetes Mellitus diagnosis, Diabetes Mellitus epidemiology, Hypertension diagnosis, Hypertension epidemiology
- Abstract
Background: Testing for the risk factors of cardiovascular disease, which include hypertension, diabetes, and hypercholesterolaemia, is important for timely and effective risk management. Yet few studies have quantified and analysed testing of cardiovascular risk factors in low-income and middle-income countries (LMICs) with respect to sociodemographic inequalities. We aimed to address this knowledge gap., Methods: In this cross-sectional analysis, we pooled individual-level data for non-pregnant adults aged 18 years or older from nationally representative surveys done between Jan 1, 2010, and Dec 31, 2019 in LMICs that included a question about whether respondents had ever had their blood pressure, glucose, or cholesterol measured. We analysed diagnostic testing performance by quantifying the overall proportion of people who had ever been tested for these cardiovascular risk factors and the proportion of individuals who met the diagnostic testing criteria in the WHO package of essential noncommunicable disease interventions for primary care (PEN) guidelines (ie, a BMI >30 kg/m
2 or a BMI >25 kg/m2 among people aged 40 years or older). We disaggregated and compared diagnostic testing performance by sex, wealth quintile, and education using two-sided t tests and multivariable logistic regression models., Findings: Our sample included data for 994 185 people from 57 surveys. 19·1% (95% CI 18·5-19·8) of the 943 259 people in the hypertension sample met the WHO PEN criteria for diagnostic testing, of whom 78·6% (77·8-79·2) were tested. 23·8% (23·4-24·3) of the 225 707 people in the diabetes sample met the WHO PEN criteria for diagnostic testing, of whom 44·9% (43·7-46·2) were tested. Finally, 27·4% (26·3-28·6) of the 250 573 people in the hypercholesterolaemia sample met the WHO PEN criteria for diagnostic testing, of whom 39·7% (37·1-2·4) were tested. Women were more likely than men to be tested for hypertension and diabetes, and people in higher wealth quintiles compared with those in the lowest wealth quintile were more likely to be tested for all three risk factors, as were people with at least secondary education compared with those with less than primary education., Interpretation: Our study shows opportunities for health systems in LMICs to improve the targeting of diagnostic testing for cardiovascular risk factors and adherence to diagnostic testing guidelines. Risk-factor-based testing recommendations rather than sociodemographic characteristics should determine which individuals are tested., Funding: Harvard McLennan Family Fund, the Alexander von Humboldt Foundation, and the National Heart, Lung, and Blood Institute of the US National Institutes of Health., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
37. Macrovascular and renal microvascular complications in West Africans with intermediate hyperglycemia living in West Africa and Europe: The RODAM study.
- Author
-
Bannerman-Williams E, Hayfron-Benjamin CF, Atiase Y, Bahendeka S, Meeks K, Klipstein-Grobusch K, Addo J, Mockenhaupt F, Schulze MB, Beune E, van den Born BJ, and Agyemang C
- Abstract
Background: Metabolic conditions, including intermediate hyperglycemia (IH), affect migrants to a greater extent than the populations of origin. Evidence suggests that IH increases the risk of vascular complications, but it is unclear whether the differences in IH between the non-migrant and migrant populations translate to differences in vascular complications between the two populations. We compared the prevalence of macrovascular and renal microvascular complications among West Africans with IH living in West Africa and their migrant compatriots in Europe., Methods: Data from the multicenter Research on Obesity and Diabetes among African Migrants(RODAM) study were analyzed. Ghanaians with IH(524 non-migrant and 1439 migrants) were included. Logistic regression analyses were used to determine the associations between migrant status and macrovascular [coronary artery disease(CAD) and peripheral artery disease(PAD)] and renal microvascular[nephropathy] complications with adjustment for age, sex, socioeconomic status, smoking, systolic blood pressure, BMI, total cholesterol, HbA1c, C-reactive protein, and serum uric acid., Findings: The prevalence of microvascular/macrovascular complications was higher in non-migrants than in migrants(nephropathy 15.3vs.9.7%; PAD 3.1%vs.1.3%; and CAD 15.8% vs. 5.0%). The differences persisted in the fully adjusted model: nephropathy [odds ratio, 2.12; 95% CI(1.46-3.08); PAD, 4.44(1.87-10.51); CAD 2.35(1.64-3.37)]. Non-migrant females had higher odds of nephropathy[2.14(1.34-3.43)], PAD[7.47(2.38-23.40)] and CAD [2.10(1.34-3.27)] compared to migrant females. Non-migrant males had higher odds of nephropathy[2.54(1.30-4.97)] and CAD[2.85(1.48-5.50)], but not PAD[1.81(0.32-10.29)],than their migrant peers., Interpretation: Macrovascular and renal microvascular complications were more prevalent in non-migrants than in migrant West Africans with IH. Further studies are needed to identify factors that increase the risk to aid preventive/treatment strategies., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
38. Subgroups of adult-onset diabetes: a data-driven cluster analysis in a Ghanaian population.
- Author
-
Danquah I, Mank I, Hampe CS, Meeks KAC, Agyemang C, Owusu-Dabo E, Smeeth L, Klipstein-Grobusch K, Bahendeka S, Spranger J, Mockenhaupt FP, Schulze MB, and Rolandsson O
- Subjects
- Humans, Adult, Male, Middle Aged, Aged, Adolescent, Ghana epidemiology, Cross-Sectional Studies, Insulin, Obesity complications, Obesity epidemiology, Cluster Analysis, Diabetes Mellitus, Type 2 complications, Diabetes Complications complications, Retinal Diseases complications, Stroke complications
- Abstract
Adult-onset diabetes mellitus (here: aDM) is not a uniform disease entity. In European populations, five diabetes subgroups have been identified by cluster analysis using simple clinical variables; these may elucidate diabetes aetiology and disease prognosis. We aimed at reproducing these subgroups among Ghanaians with aDM, and establishing their importance for diabetic complications in different health system contexts. We used data of 541 Ghanaians with aDM (age: 25-70 years; male sex: 44%) from the multi-center, cross-sectional Research on Obesity and Diabetes among African Migrants (RODAM) Study. Adult-onset DM was defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L, documented use of glucose-lowering medication or self-reported diabetes, and age of onset ≥ 18 years. We derived subgroups by cluster analysis using (i) a previously published set of variables: age at diabetes onset, HbA1c, body mass index, HOMA-beta, HOMA-IR, positivity of glutamic acid decarboxylase autoantibodies (GAD65Ab), and (ii) Ghana-specific variables: age at onset, waist circumference, FPG, and fasting insulin. For each subgroup, we calculated the clinical, treatment-related and morphometric characteristics, and the proportions of objectively measured and self-reported diabetic complications. We reproduced the five subgroups: cluster 1 (obesity-related, 73%) and cluster 5 (insulin-resistant, 5%) with no dominant diabetic complication patterns; cluster 2 (age-related, 10%) characterized by the highest proportions of coronary artery disease (CAD, 18%) and stroke (13%); cluster 3 (autoimmune-related, 5%) showing the highest proportions of kidney dysfunction (40%) and peripheral artery disease (PAD, 14%); and cluster 4 (insulin-deficient, 7%) characterized by the highest proportion of retinopathy (14%). The second approach yielded four subgroups: obesity- and age-related (68%) characterized by the highest proportion of CAD (9%); body fat-related and insulin-resistant (18%) showing the highest proportions of PAD (6%) and stroke (5%); malnutrition-related (8%) exhibiting the lowest mean waist circumference and the highest proportion of retinopathy (20%); and ketosis-prone (6%) with the highest proportion of kidney dysfunction (30%) and urinary ketones (6%). With the same set of clinical variables, the previously published aDM subgroups can largely be reproduced by cluster analysis in this Ghanaian population. This method may generate in-depth understanding of the aetiology and prognosis of aDM, particularly when choosing variables that are clinically relevant for the target population., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
39. Implementing digital systems in diabetes care in low-income and middle-income countries: successes and challenges.
- Author
-
Bahendeka S
- Subjects
- Humans, Poverty, Income, Developing Countries, Diabetes Mellitus therapy
- Abstract
Competing Interests: I declare no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
40. Type 1 diabetes patient experiences and management practices during the COVID-19 pandemic in rural Uganda.
- Author
-
Sseguya W, James S, Bwambale M, L Klatman E, D Ogle G, Munyagwa M, Maniam J, Wesonga R, and Bahendeka S
- Abstract
Background: The COVID-19 pandemic has impacted various aspects of the lives of persons with chronic diseases, including type 1 diabetes (T1D). However, the diabetes care experiences and practices adopted by persons living with T1D after the declaration of the COVID-19 pandemic in Uganda have not been well documented., Objectives: We investigated diabetes management practices and experiences of persons with T1D during the COVID-19 pandemic lockdown in a rural district of southwestern Uganda., Methods: Using interactive sequential explanatory mixed methods, we conducted a cross-sectional study of persons with T1D aged 18-25 years, their caregivers and health workers. Quantitative data was exclusively collected from patients with T1D using Kobo Toolbox™ and analysed with SPSS™ version 26; qualitative interviews were used to elicit responses from purposively selected patients with T1D, plus caregivers and health workers that were analysed using a thematic framework approach., Results: The study enrolled 51 (24 males) patients with T1D; diabetes duration (mean ± SD) 6.6 ± 5 years. Access to insulin syringes significantly worsened in 19.6% of participants ( p = 0.03 ). Insulin injection frequency (p = 0.01 ), blood glucose monitoring ( p = 0.001 ) and meal frequency ( p = 0.0001 ) significantly decreased. Qualitative interviews highlighted COVID-19 restriction measures had reduced household income, frequency of clinic visits, and access to food, diabetes support and social services., Conclusions: Experiences and practices were consistent with decisions to prioritise survival, even with known risks around metabolic control., Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-023-01222-4., Competing Interests: Competing interestsThe authors have no competing interests to declare that are relevant to the content of this article., (© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
- Published
- 2023
- Full Text
- View/download PDF
41. Epigenome-wide association study of plasma lipids in West Africans: the RODAM study.
- Author
-
van der Linden EL, Meeks KAC, Chilunga F, Hayfron-Benjamin C, Bahendeka S, Klipstein-Grobusch K, Venema A, van den Born BJ, Agyemang C, Henneman P, and Adeyemo A
- Subjects
- Humans, African People, Cholesterol, DNA Methylation, Genome-Wide Association Study, Ghana, Longitudinal Studies, Triglycerides, Epigenesis, Genetic, Epigenome, Lipids blood
- Abstract
Background: DNA-methylation has been associated with plasma lipid concentration in populations of diverse ethnic backgrounds, but epigenome-wide association studies (EWAS) in West-Africans are lacking. The aim of this study was to identify DNA-methylation loci associated with plasma lipids in Ghanaians., Methods: We conducted an EWAS using Illumina 450k DNA-methylation array profiles of extracted DNA from 663 Ghanaian participants. Differentially methylated positions (DMPs) were examined for association with plasma total cholesterol (TC), LDL-cholesterol, HDL-cholesterol, and triglycerides concentrations using linear regression models adjusted for age, sex, body mass index, diabetes mellitus, and technical covariates. Findings were replicated in independent cohorts of different ethnicities., Findings: We identified one significantly associated DMP with triglycerides (cg19693031 annotated to TXNIP, regression coefficient beta -0.26, false discovery rate adjusted p-value 0.001), which replicated in-silico in South African Batswana, African American, and European populations. From the top five DMPs with the lowest nominal p-values, two additional DMPs for triglycerides (CPT1A, ABCG1), two DMPs for LDL-cholesterol (EPSTI1, cg13781819), and one for TC (TXNIP) replicated. With the exception of EPSTI1, these loci are involved in lipid transport/metabolism or are known GWAS-associated loci. The top 5 DMPs per lipid trait explained 9.5% in the variance of TC, 8.3% in LDL-cholesterol, 6.1% in HDL-cholesterol, and 11.0% in triglycerides., Interpretation: The top DMPs identified in this study are in loci that play a role in lipid metabolism across populations, including West-Africans. Future studies including larger sample size, longitudinal study design and translational research is needed to increase our understanding on the epigenetic regulation of lipid metabolism among West-African populations., Funding: European Commission under the Framework Programme (grant number: 278901)., Competing Interests: Declaration of interests E.L.L. is a voluntary member of the junior council of Amsterdam Public Health Research Institute, Global Health section. All other authors declared no conflicts., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda.
- Author
-
Lumu W, Bahendeka S, Wesonga R, Kibirige D, Kasoma RM, and Ssendikwanawa E
- Subjects
- Female, Humans, Middle Aged, Male, Risk Factors, Glycated Hemoglobin, Cross-Sectional Studies, Uganda epidemiology, Triglycerides, Heart Disease Risk Factors, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 epidemiology, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Atherosclerosis epidemiology
- Abstract
Background: Atherogenic Index of Plasma (AIP) is a reliable predictor of coronary artery disease. There is paucity of data on AIP and its correlates among patients with type 2 diabetes (T2D) in Uganda., Objective: To assess the profile of AIP and its cardiovascular risk factor correlates among patients with T2D in Uganda., Methods: This was a cross-sectional study conducted in 8 health facilities with established T2D clinics in Central-Uganda. The study enrolled 500 patients aged 40 to 79 years. Data was collected on socio-demographic characteristics, lipid profile and glycated haemoglobin (HbA1c). The AIP was derived using log (triglycerides/high-density cholesterol) and further categorised as low cardiovascular disease (CVD) risk if the AIP was <0.1, intermediate risk (0.1-0.24) and high risk (≥0.24). Cardiovascular risk factors were defined according to international guidelines.Stata version 14 was used to analyse data, Pearson correlation analyses were conducted. Statistical significance was set at p<0.05., Results: There were 389(77.4%) females with a mean age of 55.07±8. 979 years. Low-risk was found in 43.6%, intermediate risk in 20.2% and high risk in 36.2% of the participants. AIP significantly correlated with waist circumference (r=0.1095, p<0.0147), waist-hip ratio (r=0.1926, p<0.001), Casteri Risk Index I (r=0.506, r=<0.001), Casteri Risk Index II (r=0.246, p<0.001) and atherogenic coefficient (r=0.186, p<0.001). Insignificant correlation was observed between AIP and fasting blood sugar (r=0.017, p=0.7042), HBA1C (r=0.0108, p=0.8099) and diabetes duration (r=0.0445, p=0.32)., Conclusions: AIP is significantly elevated and correlated with cardiovascular risk factors in patients with T2D. In clinical management, this may be a useful tool in risk stratifying patients with T2D., Competing Interests: None., (© 2023 Lumu W et al.)
- Published
- 2023
- Full Text
- View/download PDF
43. Associations of psychosocial stress with type 2 diabetes and glycaemic control among Ghanaians: The RODAM study.
- Author
-
Chilunga FP, Schwerzel PS, Meeks KAC, Beune E, Bahendeka S, Mockenhaupt F, Klipstein-Grobusch K, and Agyemang C
- Subjects
- Female, Humans, Male, Middle Aged, Ghana epidemiology, Glycated Hemoglobin, Glycemic Control, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 psychology, Stress, Psychological epidemiology, Stress, Psychological complications
- Abstract
Background: The extent to which psychosocial stress relates to type 2 diabetes among sub-Saharan Africans is not well understood. We assessed associations of psychosocial stresses with type 2 diabetes status and glycaemic control among Ghanaians., Methods: We used data from Research on Obesity and Diabetes among African Migrants (RODAM) study. We performed logistic and linear regression models to assess association of psychosocial stresses with type 2 diabetes and HbA1c respectively with adjustments for age, sex, education and other stresses. We also assessed moderation effects of migration status (migrant Ghanaians vs. non-migrant Ghanaians), age, sex and education by adding interaction terms in models., Results: Four thousand eight hundred and forty one Ghanaians were included with 44% resident in Ghana, 62% women, mean age of 46 years and 10% having type 2 diabetes. Psychosocial stress at home and at work were not associated with type 2 diabetes or HbA1c levels. Negative life events in past 12 months were negatively associated with type 2 diabetes (adjusted odds ratio = 0.93, 95% CI 0.87-0.99). Perceived discrimination was positively associated with type 2 diabetes (aOR = 1.01, 95% CI 1.004-1.03). Both associations were more pronounced in men. Perceived discrimination was also positively associated with HbA1c levels, especially among those with type 2 diabetes (adjusted β = 0.01, 95% CI 0.007-0.02)., Conclusions: Perceived discrimination and negative life events are associated with type 2 diabetes and glycaemic control among Ghanaians, especially in men. Further studies are needed to identify context-specific mechanisms underlying these associations., (© 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.)
- Published
- 2023
- Full Text
- View/download PDF
44. Estimating the total incidence of type 1 diabetes in children and adolescents aged 0-19 years from 1990 to 2050: a global simulation-based analysis.
- Author
-
Ward ZJ, Yeh JM, Reddy CL, Gomber A, Ross C, Rittiphairoj T, Manne-Goehler J, Abdalla AT, Abdullah MA, Ahmed A, Ankotche A, Azad K, Bahendeka S, Baldé N, Jain SM, Kalobu JC, Karekezi C, Kol H, Prasannakumar KM, Leik SK, Mbanya JC, Mbaye MN, Niang B, Paturi VR, Raghupathy P, Ramaiya K, Sethi B, Zabeen B, and Atun R
- Subjects
- Child, Adolescent, Humans, Incidence, Computer Simulation, Forecasting, Europe epidemiology, Global Health, Diabetes Mellitus, Type 1 epidemiology
- Abstract
Background: Previous studies of type 1 diabetes in childhood and adolescence have found large variations in reported incidence around the world. However, it is unclear whether these reported incidence levels are impacted by differences in country health systems and possible underdiagnosis and if so, to what degree. The aim of this study was to estimate both the total and diagnosed incidence of type 1 diabetes globally and to project childhood type 1 diabetes incidence indicators from 1990 to 2050 for each country., Methods: We developed the type 1 diabetes global microsimulation model to simulate the natural history and diagnosis of type 1 diabetes for children and adolescents (aged 0-19 years) in 200 countries and territories, accounting for variability in underlying incidence and health system performance. The model follows an open population of children and adolescents in monthly intervals and simulates type 1 diabetes incidence and progression, as well as health system factors which influence diagnosis. We calibrated the model to published data on type 1 diabetes incidence, autoantibody profiles, and proportion of cases diagnosed with diabetic ketoacidosis from 1990 to 2020 and assessed the predictive accuracy using a randomly sampled test set of data withheld from calibration., Findings: We estimate that in 2021 there were 355 900 (95% UI 334 200-377 300) total new cases of type 1 diabetes globally among children and adolescents, of which 56% (200 400 cases, 95% UI 180 600-219 500) were diagnosed. Estimated underdiagnosis varies substantially by region, with over 95% of new cases diagnosed in Australia and New Zealand, western and northern Europe, and North America, but less than 35% of new cases diagnosed in west Africa, south and southeastern Asia, and Melanesia. The total number of incident childhood cases of type 1 diabetes is projected to increase to 476 700 (95% UI 449 500-504 300) in 2050., Interpretation: Our research indicates that the total global incidence of childhood and adolescent type 1 diabetes is larger than previously estimated, with nearly one-in-two children currently undiagnosed. Policymakers should plan for adequate diagnostic and medical capacity to improve timely type 1 diabetes detection and treatment, particularly as incidence is projected to increase worldwide, with highest numbers of new cases in Africa., Funding: Novo Nordisk., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
45. Hypertension determinants among Ghanaians differ according to location of residence: RODAM study.
- Author
-
van der Linden EL, Meeks KAC, Klipstein-Grobusch K, Bahendeka S, Beune EJAJ, van den Born BH, and Agyemang C
- Subjects
- Black People, Body Mass Index, Female, Ghana epidemiology, Humans, Male, Waist Circumference, Hypertension epidemiology
- Abstract
Objective: Hypertension prevalence is high among African migrants, but the determinants of hypertension in migrants in Europe in relation to the population in the country of origin still needs to be elucidated. Therefore, the aim of this study was to assess the determinants of hypertension in Ghanaians residing in Ghana and Europe., Methods: The current study used baseline data of 5659 participants, aged 25-70 years, of the Research on Obesity and Diabetes among African Migrants study. Multivariate logistic regression analysis was used to assess sociodemographic, lifestyle, psychosocial, anthropometric and health factors independently associated with hypertension in Ghanaians living in rural and urban Ghana, and Ghanaian migrants living in Europe., Results: Across all sites, older age (both sexes; odds ratio 1.07, 95% confidence interval 1.06-1.08) and diabetes (females only; 2.02, 1.54-1.67) were independently associated with hypertension. The other determinants of hypertension differed between geographical locations. Higher waist circumference (1.12, 1.05-1.20) was independently associated with hypertension in rural-Ghanaian males, as was higher body mass index (1.15, 1.03- 1.28) in urban-Ghanaian males, higher waist circumference (1.04, 1.01-1.07) and diabetes (1.75, 1.17-2.63) in European-Ghanaian males. In European-Ghanaian females, high alcohol intake (1.88, 1.01 -3.53) and waist circumference (1.04, 1.02- 1.06) were associated with hypertension, whereas in rural-Ghanaian females, a higher educational level (0.28, 0.08-0.98) was inversely associated with hypertension., Conclusion: The current study identified several modifiable determinants of hypertension in Ghanaians, with differences between populations residing in various geographical locations. This highlights the importance of development and implementation of context-specific interventions targeting these determinants to reduce the burden of hypertension among Ghanaian migrants and nonmigrants., (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
46. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
- Author
-
Marcus ME, Manne-Goehler J, Theilmann M, Farzadfar F, Moghaddam SS, Keykhaei M, Hajebi A, Tschida S, Lemp JM, Aryal KK, Dunn M, Houehanou C, Bahendeka S, Rohloff P, Atun R, Bärnighausen TW, Geldsetzer P, Ramirez-Zea M, Chopra V, Heisler M, Davies JI, Huffman MD, Vollmer S, and Flood D
- Subjects
- Adult, Aged, Cross-Sectional Studies, Developing Countries, Female, Health Surveys statistics & numerical data, Humans, Male, Middle Aged, Cardiovascular Diseases prevention & control, Global Health statistics & numerical data, Health Surveys methods, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
- Abstract
Background: In the prevention of cardiovascular disease, a WHO target is that at least 50% of eligible people use statins. Robust evidence is needed to monitor progress towards this target in low-income and middle-income countries (LMICs), where most cardiovascular disease deaths occur. The objectives of this study were to benchmark statin use in LMICs and to investigate country-level and individual-level characteristics associated with statin use., Methods: We did a cross-sectional analysis of pooled, individual-level data from nationally representative health surveys done in 41 LMICs between 2013 and 2019. Our sample consisted of non-pregnant adults aged 40-69 years. We prioritised WHO Stepwise Approach to Surveillance (STEPS) surveys because these are WHO's recommended method for population monitoring of non-communicable disease targets. For countries in which no STEPS survey was available, a systematic search was done to identify other surveys. We included surveys that were done in an LMIC as classified by the World Bank in the survey year; were done in 2013 or later; were nationally representative; had individual-level data available; and asked questions on statin use and previous history of cardiovascular disease. Primary outcomes were the proportion of eligible individuals self-reporting use of statins for the primary and secondary prevention of cardiovascular disease. Eligibility for statin therapy for primary prevention was defined among individuals with a history of diagnosed diabetes or a 10-year cardiovascular disease risk of at least 20%. Eligibility for statin therapy for secondary prevention was defined among individuals with a history of self-reported cardiovascular disease. At the country level, we estimated statin use by per-capita health spending, per-capita income, burden of cardiovascular diseases, and commitment to non-communicable disease policy. At the individual level, we used modified Poisson regression models to assess statin use alongside individual-level characteristics of age, sex, education, and rural versus urban residence. Countries were weighted in proportion to their population size in pooled analyses., Findings: The final pooled sample included 116 449 non-pregnant individuals. 9229 individuals reported a previous history of cardiovascular disease (7·9% [95% CI 7·4-8·3] of the population-weighted sample). Among those without a previous history of cardiovascular disease, 8453 were eligible for a statin for primary prevention of cardiovascular disease (9·7% [95% CI 9·3-10·1] of the population-weighted sample). For primary prevention of cardiovascular disease, statin use was 8·0% (95% CI 6·9-9·3) and for secondary prevention statin use was 21·9% (20·0-24·0). The WHO target that at least 50% of eligible individuals receive statin therapy to prevent cardiovascular disease was achieved by no region or income group. Statin use was less common in countries with lower health spending. At the individual level, there was generally higher statin use among women (primary prevention only, risk ratio [RR] 1·83 [95% CI 1·22-2·76), and individuals who were older (primary prevention, 60-69 years, RR 1·86 [1·04-3·33]; secondary prevention, 50-59 years RR 1·71 [1·35-2·18]; and 60-69 years RR 2·09 [1·65-2·65]), more educated (primary prevention, RR 1·61 [1·09-2·37]; secondary prevention, RR 1·28 [0·97-1·69]), and lived in urban areas (secondary prevention only, RR 0·82 [0·66-1·00])., Interpretation: In a diverse sample of LMICs, statins are used by about one in ten eligible people for the primary prevention of cardiovascular diseases and one in five eligible people for secondary prevention. There is an urgent need to scale up statin use in LMICs to achieve WHO targets. Policies and programmes that facilitate implementation of statins into primary health systems in these settings should be investigated for the future., Funding: National Clinician Scholars Program at the University of Michigan Institute for Healthcare Policy and Innovation, and National Institute of Diabetes and Digestive and Kidney Diseases., Translation: For the Spanish translation of the abstract see Supplementary Materials section., Competing Interests: Declaration of interests JML reports graduate research funding from the German Academic Scholarship Foundation. RA reports contracts with Novo Nordisk, Union for International Cancer Control's, National Institute for Health Research, and Sloan Memorial Kettering Hospital, outside of the submitted work. RA also reports payments or honoraria from Merck, Novartis, and F Hoffmann-La Roche, outside of the submitted work. TWB reports support from the Alexander von Humboldt Foundation. MH reports grants from the National Institutes of Health and receives salary support from Physician for Human Rights. MDH received funding in the past 3 years from the World Heart Federation to serve as its senior programme advisor for the Emerging Leaders programme, which has been supported by Boehringer Ingelheim, Novartis, Bupa, and AstraZeneca. MDH also received support from the American Heart Association, Verily, AstraZeneca, and American Medical Association for work unrelated to this research. MDH plans to submit patents for heart failure polypill. MDH has received meeting or travel support from the American Heart Association and World Heart Federation. MDH has an appointment at The George Institute for Global Health, which has a patent, licence, and has received investment funding with intent to commercialise fixed-dose combination therapy through its social enterprise business, George Medicines. DF reports grant funding within the past 3 years from a Pilot and Feasibility Grant funded by the Michigan Center for Diabetes Translational Research (NIH Grant P30-DK092926) and a grant from the Swinmurn Foundation to implement a sustainable diabetes clinic in Guatemala. DF also reports volunteer affiliations with Wuqu’ Kawoq and GlucoSalud, outside of the submitted work. During the course of this study, DF has received research fellowship funding from National Clinician Scholars Program at the University of Michigan Institute for Healthcare Policy & Innovation. All other authors declare no competing interests., (Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
47. Serum potassium concentration and its association with hypertension among Ghanaian migrants and non-migrants: The RODAM study.
- Author
-
Ndong AK, van der Linden EL, Beune EJAJ, Meeks KAC, Danquah I, Bahendeka S, Klipstein-Grobusch K, Schulze MB, Addo J, van den Born BH, and Agyemang C
- Subjects
- Cross-Sectional Studies, Female, Ghana epidemiology, Humans, Male, Potassium, Prevalence, Hypertension diagnosis, Hypertension epidemiology, Transients and Migrants
- Abstract
Background and Aims: Low serum potassium concentration is associated with hypertension, but whether the same association can be found in African origin populations, is unknown. We assessed serum potassium concentration, and its association with hypertension among Ghanaians living in different geographical locations., Methods: Baseline data of 962 rural, 1420 urban, and 2947 migrant Ghanaians from the Research on Obesity and Diabetes among African Migrants study were analysed. Mean serum potassium concentration was compared between the groups, and the association between serum potassium and hypertension was assessed using multivariate regression analyses., Results: Mean serum potassium concentration was higher in rural Ghana (4.28, 95% confidence interval 4.25-4.32 mmol/L) than in Ghanaians living in Amsterdam (3.90, 3.88-3.92 mmol/L) and London (4.11, 4.07-4.14 mmol/L), but lower than in Ghanaians living in urban Ghana (4.38, 4.34-4.42 mmol/L) and Berlin (4.57, 4.51-4.62 mmol/L) in both sexes. In the age-adjusted analyses, serum potassium was associated with hypertension in urban- (odds ratio 0.44, 0.23-0.82), London- (0.34, 0.17-0.64) and Amsterdam-Ghanaian males (0.41, 0.20-0.86), and in rural- (0.49, 0.28-0.84), London- (0.29, 0.17-0.49) and Amsterdam-Ghanaian females (0.33, 0.17-0.64). However, after adjustment for demographic, lifestyle, and health factors, serum potassium was associated with hypertension in Amsterdam-Ghanaian males only (0.12, 0.02-0.59)., Conclusions: This study shows differences in mean serum potassium among Ghanaian populations living in different locations in Europe and Ghana, and different associations with hypertension between sites. Further research should focus on elucidating the mechanism underlying potassium handling and blood pressure regulation in African populations, in order to mitigate the burden of hypertension among these populations., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
48. C-reactive protein and hypertension among Ghanaian migrants and their homeland counterparts: the Research on Obesity and Diabetes among African Migrants study.
- Author
-
van Apeldoorn JAN, van der Linden EL, Bahendeka S, Beune E, Meeks KAC, Klipstein-Grobusch K, van den Born BJ, and Agyemang C
- Subjects
- Adolescent, Adult, C-Reactive Protein, Cross-Sectional Studies, Female, Ghana epidemiology, Humans, Male, Obesity epidemiology, Prevalence, Risk Factors, Diabetes Mellitus epidemiology, Hypertension epidemiology, Transients and Migrants
- Abstract
Background: Hypertension (HTN) is a growing public health problem in sub-Saharan Africa (SSA) and SSA migrants in Europe. Elevated levels of inflammatory marker C-reactive protein (CRP) have been linked to HTN but the relationship of CRP and HTN among SSA populations has not been studied. To address this knowledge gap, we studied the association between CRP and HTN in migrant and nonmigrant SSA populations residing in different settings., Methods: Cross-sectional data from the multicentre Research on Obesity and Diabetes among African Migrants (RODAM) study were analysed including 5683 Ghanaians aged at least 18 years, residing in rural and urban Ghana, and Europe. Multivariate logistic regression analyses were used to assess the association between high levels of CRP (≥3 mg/l) and HTN (SBP ≥140 mmHg and/or DBP ≥90 mmHg and/or use of antihypertensive medication) per geographical site and sex., Results: The association between CRP levels and HTN varied by sex and geographical location. In age-adjusted models, there was an association between high CRP levels and HTN in urban-Ghanaian women (odds ratio 1.50, 95% confidence interval 1.10-2.03), and European-Ghanaian men (1.68, 1.16-2.43) and women (1.63, 1.28-2.07). However, these associations were attenuated after adjustment for conventional risk factors, especially BMI. No association was found in rural-Ghanaians or urban-Ghanaian men., Conclusion: Our findings show an association between CRP and HTN among Ghanaian migrants and urban-Ghanaian women, however, this was largely explained by conventional risk factors. Thus, prevention of conventional risk factors, in particular obesity, may help to reduce the potentially low-grade inflammatory mechanism underlying HTN., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
49. Multimorbidity Among Migrant and Non-Migrant Ghanaians: The RODAM Study.
- Author
-
Marzà-Florensa A, Boateng D, Agyemang C, Beune E, Meeks KAC, Bahendeka S, Levitt N, and Klipstein-Grobusch K
- Subjects
- Cross-Sectional Studies, Female, Ghana epidemiology, Humans, Male, Multimorbidity, Prevalence, Rural Population, Transients and Migrants
- Abstract
Objectives: Multimorbidity is a growing public health concern due to the increasing burden of non-communicable diseases, yet information about multimorbidity in low- and middle-income countries and migrant populations is scarce. We aimed to investigate the distribution and patterns of multimorbidity in rural and urban areas in Ghana and Ghanaian migrants in Europe. Methods: The RODAM cross-sectional study included 4,833 participants. Multimorbidity was defined as presence of multiple non-communicable chronic conditions. Patterns were determined from frequent combination of conditions. Prevalence ratios were estimated by logistic regression. Results: Prevalence of multimorbidity was higher in women and in urban Ghana and Europe. We observed a cardiometabolic pattern in all sites as well as circulatory-musculoskeletal and metabolic-musculoskeletal combinations in Ghana. Multimorbidity prevalence ratios were higher in Europe (men 1.47, 95% CI 1.34-1.59, women 1.18, 1.10-1.26) and urban Ghana (men 1.46, 1.31-1.59, women 1.27, 1.19-1.34). Conclusion: Distribution and patterns of multimorbidity differed by sex and site. With a higher burden of multimorbidity in urban areas, prevention strategies should focus on forestalling its increase in rapidly growing rural areas., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Marzà-Florensa, Boateng, Agyemang, Beune, Meeks, Bahendeka, Levitt and Klipstein-Grobusch.)
- Published
- 2021
- Full Text
- View/download PDF
50. Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study.
- Author
-
Osei TB, van Dijk AM, Dingerink S, Chilunga FP, Beune E, Meeks KAC, Bahendeka S, Schulze MB, Agyemang C, Nicolaou M, Holleboom AG, and Danquah I
- Subjects
- Adult, Black People ethnology, Cross-Sectional Studies, Diabetes Mellitus, Type 2 ethnology, Diet adverse effects, Diet ethnology, Europe epidemiology, Female, Ghana epidemiology, Ghana ethnology, Humans, Male, Middle Aged, Non-alcoholic Fatty Liver Disease ethnology, Odds Ratio, Regression Analysis, Severity of Illness Index, Sex Factors, Black People statistics & numerical data, Diabetes Mellitus, Type 2 epidemiology, Diet statistics & numerical data, Feeding Behavior ethnology, Non-alcoholic Fatty Liver Disease complications, Transients and Migrants statistics & numerical data
- Abstract
The Fatty Liver Index (FLI) is a proxy for the steatotic component of non-alcoholic fatty liver disease (NAFLD). For sub-Saharan African populations, the contribution of dietary factors to the development of NAFLD in the etiology of type 2 diabetes mellitus (T2DM) remains to be clarified. We identified sex-specific dietary patterns (DPs) related to the FLI using reduced ranked regression (RRR) and evaluated the associations of these DPs with T2DM. This analysis used data from the RODAM, a multi-center cross-sectional study of Ghanaian populations living in Ghana and Europe. The daily intake frequencies of 30 food groups served as the predictor variables, while the FLI was the response variable. The odds ratios and 95% confidence intervals for T2DM were calculated per one standard deviation increase in the DP score using logistic regression. In males, the DP score explained 9.9% of the variation in their food intake and 16.0% of the variation in the FLI. This DP was characterized by high intakes of poultry, whole-grain cereals, coffee and tea, condiments, and potatoes, and the chance of T2DM was 45% higher per 1 DP score-SD (Model 2). Our results indicate that the intake of modernized foods was associated with proxies of NAFLD, possibly underlying the metabolic pathways to developing T2DM.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.